UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z
Number of items: 487.

A

Adams, MJ; Donohoe, S; Mackie, IJ; Machin, SJ; (2001) Anti-tissue factor pathway inhibitor activity in patients with primary antiphospholipid syndrome. BRIT J HAEMATOL , 114 (2) 375 - 379.

Adeyemo, D; Imtiaz, F; Toffa, S; Lowdell, M; Wickremasinghe, RG; Winslet, M; (2001) Antioxidants enhance the susceptibility of colon carcinoma cells to 5-fluorouracil by augmenting the induction of the bax protein. CANCER LETT , 164 (1) 77 - 84.

Ahmed, F; Ings, SJ; Pizzey, A; Fahey, A; Blundell, M; Hardy, SJ; Thrasher, A; (2001) Cytokine exposure impairs short-term homing of CD34(+) cells in SCID/NOD mice: Influence of cell cycle status. BLOOD , 98 (11) 644A - 644A.

Al Saffar, N; Burrows, MG; Revell, PA; (2001) Immunopathological reaction to orthopaedic biomterial: The role of cytokines. In: Cracium, C and Ardelean, A, (eds.) Current problems in cellular and molecular biology. (pp. 37-50). : Cluk Napoca.

Ala, A; Standish, R; Khan, K; Prasad, N; Hillan, K; Dhillon, AP; Hodgson, H; (2001) Immmunohistochemical study of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression in primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC). Hepatology , 34 (4) 1404-.

Alison, MR; Poulsom, R; Jeffery, R; Dhillon, AP; Quaglia, A; Jacob, J; Novelli, M; (2001) Plasticity of adult human haemopoietic stem cells: differentiation into bile ducts after liver and bone marrow transplantation. J PATHOL , 193 5A - 5A.

Allen, AJ; Gale, RE; Harrison, CN; Machin, SJ; Linch, DC; (2001) Lack of pathogenic mutations in the 5'-untranslated region of the thrombopoietin gene in patients with non-familial essential thrombocythaemia. European Journal of Haematology , 67 (4) pp. 232-237.

Allen, AJR; Gale, RE; Harrison, CN; Machin, SJ; Linch, DC; (2001) Lack of pathogenic mutations in the 5 '-untranslated region of the thrombopoietin gene in patients with non-familial essential thrombocythaemia. EUR J HAEMATOL , 67 (4) 232 - 237.

Ancliff, PJ; Blundell, MP; Gale, RE; Liesner, R; Hann, IM; Thrasher, AJ; Linch, DC; (2001) Activating mutations in theWiskott Aldrich syndrome protein may define a sub-group of severe congenital neutropenia (SCN) with specific and unusual laboratory features. BLOOD , 98 (11) 439A - 440A.

Ancliff, PJ; Gale, RE; Hann, IM; Strobel, S; Linch, DC; (2001) Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. BLOOD , 98 (11) 439A - 439A.

Ancliff, PJ; Gale, RE; Liesner, R; Hann, IM; Linch, DC; (2001) Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. BLOOD , 98 (9) 2645 - 2650.

Anderson, LJ; Holden, S; Davis, B; Prescott, E; Charrier, CC; Bunce, NH; Firmin, DN; (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. EUR HEART J , 22 (23) 2171 - 2179. 10.1053/euhj.2001.2822.

Antin, JH; Childs, R; Filipovich, AH; Giralt, S; Mackinnon, S; Spitzer, T; Weisdorf, D; (2001) Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001 Tandem Meetings. BIOL BLOOD MARROW TR , 7 (9) 473 - 485.

Ardeshna, KM; Smith, P; Linch, DC; BNLI, ; (2001) The long-term impact of a watch and wait policy vs immediate systemic treatment for asymptomatic advanced stage indolent non Hodgkins lymphoma: Results of a British national lymphoma randomised trial. BRIT J CANCER , 85 2 - 2.

Arnold, J; Cohen, H; (2001) Erratum: Heparin-induced skin necrosis (British Journal of Haematology 111:4 (991-992)). British Journal of Haematology , 112 (4) 1091-. 10.1046/j.1365-2141.2001.02718.x.

Arnold, T; Holmes, Z; Pickering, W; Farmer, C; Regan, L; Cohen, H; (2001) Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. BRIT J HAEMATOL , 113 (4) 911 - 914.

Arulampalam, TH; Ledermann, J; Costa, DC; (2001) Asymptomatic patient with an increasing concentration of CEA. Lancet Oncol , 2 (3) 172-.

Asakawa, S; Tsunematsu, K; Takayanagi, A; Sasaki, T; Shimizu, A; Shintani, A; Kawasaki, K; (2001) The genomic structure and promoter region of the human Parkin gene. BIOCHEM BIOPH RES CO , 286 (5) 863 - 868. 10.1006/bbrc.2001.5490.

Ataman, OU; Bentzen, SM; Saunders, MI; Dische, S; (2001) Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced nonsmall-cell lung cancer: A competing risks analysis. British Journal of Cancer , 85 (8) pp. 1113-1118.

Aubert, G; Hassan-Walker, AF; Madrigal, JA; Emery, VC; Morte, C; Grace, S; Koh, MBC; (2001) Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. The Journal of Infectious Diseases , 184 (8) pp. 955-963.

Aubert, G; Hassan-Walker, AF; Madrigal, JA; Emery, VC; Morte, C; Grace, S; Koh, MBC; (2001) Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J INFECT DIS , 184 (8) 955 - 963.

B

BBC, 6ON; (2001) Thalidomide trial in lung cancer. UNSPECIFIED

BBC, N; (2001) 'My hope for Thalidomide cure'. UNSPECIFIED

BBC, NATIBFW; BBC, OTN; BBC, NB; (2001) Thalidomide is cancer weapon. UNSPECIFIED

BBC, R4IBRH; (2001) UNSPECIFIED UNSPECIFIED

Bagdi, E; Krenacs, L; Krenacs, T; Miller, K; Isaacson, PG; (2001) Follicular dendritic cells in reactive and neoplastic lymphoid tissues: A reevaluation of staining patterns of CD21, CD23, and CD35 antibodies in paraffin sections after wet heat-induced epitope retrieval. APPL IMMUNOHISTO M M , 9 (2) 117 - 124.

Bahadur, G; Whelan, J; Davies, MC; Ralph, D; (2001) Cancer patients, gametes, gonadal tissue, and the UK legal status. Reproductive Biomedicine Online , 2 (1) pp. 8-10.

Bahadur, G; Whelan, J; Ralph, D; Hindmarsh, P; (2001) Adolescent cancer patients sperm storage, consent and emotion. Human Reproduction , 16 (11) 2474-.

Bahadur, G; Whelan, J; Ralph, D; Hindmarsh, P; (2001) Gaining consent to freeze sperm from adolescents with cancer: legal, ethical and practical aspects. Human Reproduction , 16 (1) pp. 188-193.

Bainbridge, JA; Revell, PA; Al Saffar, N; (2001) Costimulatory molecule expression following exposure to orthopaedic implants wear debris. Journal of Biomedical Materials Research Part A , 54 (3) pp. 328-334.

Bates, AW; (2001) The De monstrorum of Fortunio Liceti: a landmark of descriptive teratology. J Med Biogr , 9 (1) pp. 49-54. 10.1177/096777200100900112.

Bates, AW; (2001) A case of Roberts syndrome described in 1737. J MED GENET , 38 (8) 565 - 567.

Bates, AW; Smith, VV; (2001) Symptomatic diffuse colonic lipomatosis in Proteus syndrome. HISTOPATHOLOGY , 39 (1) 103 - 104.

Beck, S; (2001) Genome acrobatics: understanding complex genomes. DRUG DISCOV TODAY , 6 (23) 1181 - 1182.

Bench, AJ; Cross, NCP; Huntly, BJP; Nacheva, EP; Green, AR; (2001) Myeloproliferative disorders. In: BEST PRACT RES CL HA. (pp. 531 - 551). BAILLIERE TINDALL

Bennett, CL; Misslitz, A; Colledge, L; Aebischer, T; Blackburn, CC; (2001) Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. EUROPEAN JOURNAL OF IMMUNOLOGY , 31 (3) pp. 876-883. 10.1002/1521-4141(200103)31:3<876::AID-IMMU876>3.0.CO;2-I.

Bennett, PM; Jepson, PD; Law, RJ; Jones, BR; Kuiken, T; Baker, JR; Rogan, E; (2001) Exposure to heavy metals and infectious disease mortality in harbour porpoises from England and Wales. ENVIRONMENTAL POLLUTION , 112 (1) pp. 33-40. 10.1016/S0269-7491(00)00105-6.

Bentzen, SA; Saunders, MI; Dische, S; Bond, SJ; (2001) Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiotherapy And Oncology , 60 (2) pp. 123-135.

Bentzen, SM; Saunders, MI; Dische, S; Parmar, MK; (2001) Accelerated radiotherapy vs. chemoradiation in non-small cell lung cancer: quantifying the hazards. Radiother Oncol , 58 (1) pp. 91-92.

Berger, LA; Warwick, R; Mehta, A; (2001) Isolated Candida infection of the pterygoid muscles in a patient with Gaucher's disease. American Journal of Roentgenology , 176 1332-.

Bernassola, F; Salomoni, P; Melino, G; Pandolfi, PP; (2001) PML modulates p73-dependent transcription and apoptosis. BLOOD , 98 (11) 758A - 758A.

Bilanges, B; Varrault, A; Mazumdar, A; Pantaloni, C; Hoffmann, A; Bockaert, J; Spengler, D; (2001) Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities. Oncogene , 20 (10) pp. 1246-1253. 10.1038/sj.onc.1204237.

Boddy, AV; Griffin, MJ; Sludden, J; Thomas, HD; Fishwick, K; Wright, JG; Plummer, ER; (2001) Pharmacological study of paclitaxel duration of infusion combined with GFR-based carboplatin in the treatment of ovarian cancer. CANCER CHEMOTH PHARM , 48 (1) 15 - 21.

Borras, FE; Matthews, NC; Lowdell, MW; Navarrete, CV; (2001) Identification of both myeloid CD11c(+) and lymphoid CD11c(-) dendritic cell subsets in cord blood. BRIT J HAEMATOL , 113 (4) 925 - 931.

Borràs, FE; Matthews, NC; Lowdell, MW; Navarrete, CV; (2001) Both lymphoid and myeloid subsets of dendritic cells are present in cord blood. European Journal of Immunogenetics , 28 (2) 259-.

Boshoff, C; (2001) Gammaherpesviral infections and neoplasia in immunocompromised populations. In: Smith, GL and Irving, WL and McCauley, JW and Rowlands, DJ, (eds.) NEW CHALLENGES TO HEALTH: THE THREAT OF VIRUS INFECTION. (pp. 213 - 232). CAMBRIDGE UNIV PRESS

Boshoff, C; Chang, Y; (2001) Kaposi's sarcoma - Associated herpesvirus: A new DNA tumor virus. ANNU REV MED , 52 453 - 470.

Boshoff, C; Weiss, R; (2001) Cancer processes in immunodeficient populations: an introduction. EUR J CANCER , 37 (10) 1202 - 1208.

Boshoff, C; Weiss, RA; (2001) Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. PHILOS T R SOC B , 356 (1408) 517 - 534.

Bowman, KJ; Newell, DR; Calvert, AH; Curtin, NJ; (2001) Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro. BRIT J CANCER , 84 (1) 106 - 112. 10.1054/bjoc.2000.1555.

Bownes, PJ; Hoskin, PJ; Ostler, P; (2001) Quality assurance for fractionated highdose rate afterloading brachytherapy of prostate cancer. In: (pp. S7-).

Bownes, PJ; Ostler, P; Hoskin, PJ; (2001) The effect of catheter movement on implant quality for fractionated high dose rate afterloading brachytherapy of prostate cancer. In: (pp. S30-).

Burcombe, RJ; Makris, A; Pittam, M; Lowe, J; Emett, J; Wong, WL; (2001) Evaluation of clinical complete response to neoadjuvant chemotherapy in primary breast cancer using (F-18)- fluorodeoxyglucose positron emission tomography. British Journal of Cancer , 85 p. 50.

Burcombe, RJ; Makris, A; Richman, PI; Pittam, M; Daley, F; Nobe, S; Wilson, GD; (2001) Evaluation of ER, PgR, HER2 and Ki67 as predictors of response to neoadjuvant chemotherapy for operable breast cancer. British Journal of Cancer , 85 p. 50.

Buscombe, R; Caplin, ME; Hepplewhite, J; Johnson, G; Bouloux, P; Meyer, T; Hochhauser, D; (2001) Use of radiolanreotice to treat somatostatin receptor positive tumours. European Journal of Nuclear Medicine , 28 (8) S480-.

Buscombe, R; Caplin, ME; Hepplewhite, J; Johnson, G; Bouloux, PL; Meyer, T; Hochhauser, D; (2001) Treating somatostatin receptor positive tumours with radiolanreotide. European Journal of Nuclear Medicine , 28 (8) OS253-.

Butcher, SK; Chahal, H; Nayak, L; Sinclair, A; Henriquez, NV; Sapey, E; O'Mahony, D; (2001) Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol , 70 (6) pp. 881-886.

C

Calder, JDF; Pearse, MF; Revell, PA; (2001) The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head. Journal of Bone and Joint Surgery - Series A , 83B (3) pp. 419-422.

Cardigan, RA; Crook, M; Mackie, IJ; Machin, SJ; (2001) Plasma levels of factor XIIa and factor VIIa are increased but not related in primary hyperlipidaemia. BLOOD COAGUL FIBRIN , 12 (3) 187 - 192.

Cardigan, RA; Mackie, IJ; Gippner-Steppert, C; Jochum, M; Royston, D; Gallimore, MJ; (2001) Determination of plasma aprotinin levels by functional and immunologic assays. BLOOD COAGUL FIBRIN , 12 (1) 37 - 42.

Carvalho, C; Pereira, HM; Ferreira, J; Pina, C; Mendonca, D; Rosa, AC; Carmo-Fonseca, M; (2001) Chromosomal G-dark Bands Determine the Spatial Organization of Centromeric Heterochromatin in the Nucleus. Molecular Biology of the Cell , 12 pp. 3563-3572.

Cerone, MA; Londono-Vallejo, JA; Bacchetti, S; (2001) Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum Mol Genet , 10 (18) pp. 1945-1952.

Chakrabarti, S; Mackinnon, S; Kottaridis, P; Hale, G; Osman, H; Peggs, K; Fegan, C; (2001) Community respiratory virus and adenovirus infections in nonmyeloablative transplant recipients conditioned with. Campath-1H: High incidence but low mortality. In: BLOOD. (pp. 392A - 392A). AMER SOC HEMATOLOGY

Chakraverty, R; Rabin, N; Peggs, K; Robinson, S; Duncan, JR; Yong, K; (2001) Dermatomyositis and sarcoid-like reaction associated with multiple myeloma treated effectively by high-dose chemotherapy and autologous peripheral blood stem cell transplantation. BONE MARROW TRANSPL , 27 (11) 1215 - 1217.

Chakraverty, RK; Kearsey, JM; Oakley, TJ; Grenon, M; de La Torre Ruiz, MA; Lowndes, NF; Hickson, ID; (2001) Topoisomerase III acts upstream of Rad53p in the S-phase DNA damage checkpoint. Mol Cell Biol , 21 (21) pp. 7150-7162. 10.1128/MCB.21.21.7150-7162.2001.

Chase, JC; Dawson-Coates, JA; Haddow, JD; Stewart, MH; Haines, LR; Whitaker, DJ; Ken, ML; (2001) Analysis of Kudoa thyrsites (Myxozoa: Myxosporea) spore antigens using monoclonal antibodies. Dis Aquat Organ , 45 (2) pp. 121-129. 10.3354/dao045121.

Chatterjee, R; Kottaridis, PD; McGarrigle, HH; Eliahoo, J; McKeag, N; Mackinnon, S; Goldstone, AH; (2001) Patterns of Leydig cell insufficiency in adult males following bone marrow transplantation for haematological malignancies. BONE MARROW TRANSPL , 28 (5) 497 - 502.

Chau, TN; Quaglia, A; Rolles, K; Burroughs, AK; Dhillon, AP; (2001) Histological patterns of rejection using oral microemulsified cyclosporine and tacrolimus (FK506) as monotherapy induction after orthotopic liver transplantation. LIVER , 21 (5) 329 - 334.

Chen, FE; Rawlings, E; Haque, T; Madrigal, JA; Amlot, P; (2001) Lytic antigen specificity of anti-EBV cytotoxic T cells arising in vivo during post-transplant lymphoproliferative disease parallels generation of anti-EBV specific CTL generated in vitro. Blood , 98 (11) 1688-.

Cheung, VG; Nowak, N; Jang, W; Kirsch, IR; Zhao, S; Chen, XN; Furey, TS; (2001) Integration of cytogenetic landmarks into the draft sequence of the human genome. NATURE , 409 (6822) 953 - 958.

Chitolie, A; Lawrie, AS; Mackie, IJ; Harrison, P; Machin, SJ; (2001) The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance. BLOOD COAGUL FIBRIN , 12 (3) 179 - 186.

Clark, RE; Dodi, IA; Hill, SC; Lill, JR; Aubert, G; Macintyre, AR; Rojas, J; (2001) Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood , 98 (10) pp. 2887-2893. Green open access
file

Clark, RE; Dodi, IA; Hill, SC; Lill, JR; Aubert, G; Macintyre, AR; Rojas, J; (2001) Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood , 98 (10) pp. 2887-2893.

Clarke, SA; Revell, PA; (2001) Integrin expression at the bone/biomaterial interface. Journal of Biomedical Materials Research Part A , 57 (1) pp. 84-91.

Cohen, H; (2001) Lack of an association between the -455F/A b-fibrinogen gene polymorphism and pregnancy complications. In: (Proceedings) International society of thrombosis and haemostasis.

Cohen, H; (2001) Management of Jehovah's Witness patients with haematological problems. [Lecture]. Presented at: British society for haematology annual scientific meeting, Harrogate.

Cohen, H; (2001) SHOT: the future. In: (Proceedings) SHOT annual symposium.

Condorelli, F; Salomoni, P; Cotteret, S; Cesi, V; Srinivasula, SM; Alnemri, ES; Calabretta, B; (2001) Caspase cleavage enhances the apoptosis-inducing effects of BAD. MOL CELL BIOL , 21 (9) 3025 - 3036.

Cook, DG; Cappuccio, FP; Atkinson, RW; Wicks, PD; Chitolie, A; Nakandakare, ER; Sagnella, GA; (2001) Ethnic differences in fibrinogen levels: The role of environmental factors and the beta-fibrinogen gene. AM J EPIDEMIOL , 153 (8) 799 - 806.

Cooke, S.P.; Boxer, G.M.; Lawrence, L.; Pedley, R.B.; Spencer, D.I.R.; Begent, R.H.J.; Chester, K.A.; (2001) A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor. Cancer Research , 61 (9) pp. 3653-3659.

Cooke, SP; Boxer, GM; Lawrence, L; Pedley, RB; Spencer, DIR; Begent, RHJ; Chester, KA; (2001) A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor : receptor complex. CANCER RES , 61 (9) 3653 - 3659.

Cox, ST; McWhinnie, AJ; Baker, FA; Stubbins, MJ; Allen, CJ; Holman, R; Madrigal, JA; (2001) Identification of HLA-A*2306. Tissue Antigens , 57 (1) pp. 73-75.

Cox, ST; McWhinnie, AJ; Baker, FA; Stubbins, MJ; Allen, CJ; Holman, R; Madrigal, JA; (2001) Identification of HLA-A*2306. Tissue Antigens , 57 (1) pp. 73-75.

Cox, ST; McWhinnie, AJ; Koester, RP; Heine, U; Holman, R; Madrigal, JA; Little, AM; (2001) Further diversity at HLA-A and -B loci identified in Afro- Caribbean potential bone marrow donors. Tissue Antigens , 57 (1) pp. 70-72.

Cox, ST; McWhinnie, AJ; Koester, RP; Heine, U; Holman, R; Madrigal, JA; Little, AM; (2001) Further diversity at HLA-A and -B loci identified in Afro- Caribbean potential bone marrow donors. Tissue Antigens , 57 (1) pp. 70-72.

Cox, ST; Tavarozzi, F; McWhinnie, A; Hoddinott, MA; Calvert, A; Baker, F; Madrigal, JA; (2001) HLA-B*4034 identified in a UK Caucasoid potential bone marrow donor. Immunogenetics , 53 (1) pp. 43-44.

Cox, ST; Tavarozzi, F; McWhinnie, A; Hoddinott, MA; Calvert, A; Baker, F; Madrigal, JA; (2001) HLA-B*4034 identified in a UK Caucasoid potential bone marrow donor. Immunogenetics , 53 (1) pp. 43-44.

Craddock, C; Spanswick, V; Mahendra, P; Sekhar, M; Hartley, JA; (2001) Repair of DNA interstarand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. In: (pp. 41-).

Creaser, CS; Lill, JR; Bonner, PLR; Hill, SC; Rees, RC; Christmas, SC; Clark, R; (2001) Characterisation of HLA-A3 restricted peptide from the BCR-ABL fusion protein of the Philadelphia Chromosome using Nano-electrospray ion trap mass spectrometry. Advances in Mass Spectrometry , 15 pp. 637-638.

Cullen, MH; Billingham, LJ; Woodroffe, CM; Chetiyawardana, AD; Gower, NH; Joshi, R; Ferry, DR; (2001) Mitomycin,Ifosfamide and cisplatin in unresectable non-small cell lung cancer: Effects on survival and quality of life. Classic Papers and Current Comments: Highlights of Lung Cancer Research , 6 (1) pp. 21-28.

Curtin, N; Barton, S; Batey, M; Calabrese, C; Calvert, H; Durkacz, B; Griffin, R; (2001) Anti-cancer chemosensitization in vitro and in vivo by a novel potent poly(ADP-ribose) polymerase (PARP1) inhibitor, TBI-361. CLIN CANCER RES , 7 (11) 3740S - 3740S.

D

D'Sa, SP; Peggs, KS; Thuraisundaram, D; Fox, R; Goldstone, AH; Mackinnon, S; Yong, KL; (2001) CAMPATH-1H-containing nonmyeloablative allogeneic stem cell transplantation for myeloma results in delayed T cell reconstitution and a high incidence of viral infections, but low infection-related mortality. In: BLOOD. (pp. 203A - 203A). AMER SOC HEMATOLOGY

Daily, S; (2001) Hell drug for cancer.

Damien, E; Hing, K; MacInnes, T; Revell, PA; (2001) UNSPECIFIED In: (Proceedings) Enhancement of the bioactivity of hydroxyapatite implants invivo by growth factors: Effect of Insulin like growth factor -1 and -11. : London.

Damien, E; MacInnes, T; Hing, K; Revell, PA; (2001) Insulin like growth factor (IGF-I) increases the bioactivity of porous hydroxyapatite (PHA) in vivo in rabbits. The Journal of Pathology , 193 6A-6A.

Damien, E; MacInnes, T; Revell, PA; (2001) Effects of insulin like growth factors (IGF-I and IGF-II) during osteoinduction. Journal of Bone and Mineral Research , 16 (6) 6-.

Damien, E; MacInnes, T; Revell, PA; (2001) In vivo effect of insulin like growth factor-II (IGF-II) on de novo bone formation in the presence of hydroxyapatite in rabbit femur. BONE , 28 (5) S140-S140.

David, D; (2001) Thalidomide in trials to treat lung cancer. Daily Telegraph 4-.

David, F; (2001) Birth defects drug may return. Financial Times

Davidovici, B; Karakis, I; Bourboulia, D; Ariad, S; Zong, JC; Benharroch, D; Dupin, N; (2001) Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J NATL CANCER I , 93 (3) 194 - 202.

Deloukas, P; Matthews, LH; Ashurst, J; Burton, J; Gilbert, JGR; Jones, M; Stavrides, G; (2001) The DNA sequence and comparative analysis of human chromosome 20. NATURE , 414 (6866) 865 - U3.

Dhillon, AP; (2001) Variants of autoimmune liver disease: overlap and outlier syndromes. Annals of Contemporary Diagnostic Pathology , 201 (4) pp. 9-13.

Dickson, J; Bownes, P; Ostler, P; Hoskin, PJ; (2001) Combined external beam and brachytherapy boost for localised prostate cancer: A report of procedural complications and acute radiation toxicity. In: (pp. p. 89).

Donohoe, S; Mackie, IJ; Isenberg, D; Machin, SJ; (2001) Anti-prothrombin antibodies: Assay conditions and clinical associations in the anti-phospholipid syndrome. British Journal of Haematology , 113 (2) pp. 544-549. 10.1046/j.1365-2141.2001.02716.x.

Donohoe, S; Mackie, IJ; Isenberg, D; Machin, SJ; (2001) Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome. BRIT J HAEMATOL , 113 (2) 544 - 549.

Dopazo, J; Mendoza, A; Herrero, J; Caldara, F; Humbert, Y; Friedli, L; Guerrier, M; (2001) Annotated draft genomic sequence from a Streptococcus pneumoniae type 19F clinical isolate. Microb Drug Resist , 7 (2) pp. 99-125. 10.1089/10766290152044995.

Du, MO; Liu, H; Diss, TC; Hamoudi, RA; Ye, H; Dupin, N; Oksenhendler, E; (2001) KSHV infects monotypic (IgM lambda) but polyclonal naive B- cells in Castleman's disease and associated lymphoproliferative disorders. The Journal of Pathology , 193 3A-3A.

Du, MO; Liu, H; Diss, TC; Hamoudi, RA; Ye, H; Dupin, N; Oksenhendler, E; (2001) KSHV infects monotypic (IgM lambda) but polyclonal naive B-cells in Castleman's disease and associated lymphoproliferative disorders. J PATHOL , 193 3A - 3A.

Du, MQ; Liu, H; Diss, TC; Ye, H; Hamoudi, RA; Dupin, N; Meignin, V; (2001) Kaposi sarcoma-associated herpes virus infects monotypic (IgMl) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. BLOOD , 97 (7) pp. 2130-2136.

Du, MQ; Liu, H; Diss, TC; Ye, H; Hamoudi, RA; Dupin, N; Meignin, V; (2001) Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood , 97 (7) pp. 2130-2136.

Du, MQ; Liu, HX; Diss, TC; Ye, HT; Hamoudi, RA; Dupin, N; Meignin, V; (2001) Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. BLOOD , 97 (7) 2130 - 2136.

E

Ellis, PE; Wong, TF; Rolfe, KJ; Crow, J; Reid, WMN; MacLean, AB; Perrett, CW; (2001) p53 and Ki67 expression in Paget's disease of the vulva with or without invasive disease. In: (pp. 156-).

Ellis, PE; Wong Te Fong, LF; Rolfe, KJ; Crow, JC; MacLean, AB; Perrett, CW; (2001) An examination of the role of VEGF-A and PD-ECGF/TP in Pagets disease of the vulva and the breast. Anticancer Research , 21 pp. 1632-1633.

Evans, P; Halliwell, B; (2001) Micronutrients: oxidant/antioxidant status. BRITISH JOURNAL OF NUTRITION , 85 S67-S74.

Ezoe, S; Mtsumura, I; Mizuki, M; Kawasaki, A; Machii, T; Yamamoto, M; Enver, T; (2001) Roles of P21(WAF1) and P27(KIP1) in GATA-2-induced growth suppression of hematopoietic cells. BLOOD , 98 (11) 759A-759A.

F

Farnie, G; Atkins, H; Calvert, AH; Curtin, NJ; Golding, BT; Griffin, RJ; Hardcastle, I; (2001) Inhibiting the MDM2-p53 interaction using low molecular weight compounds. BRIT J CANCER , 85 81 - 81.

Firat, H; Tourdot, S; Ureta-Vidal, A; Scardino, A; Suhrbier, A; Buseyne, F; Rivìere, Y; (2001) Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice. Eur J Immunol , 31 (10) pp. 3064-3074. 10.1002/1521-4141(2001010)31:10<3064::AID-IMMU3064>3.0.CO;2-L.

Flynn, AA; Boxer, GM; Begent, RHJ; Pedley, RB; (2001) Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images. CANCER IMMUNOL IMMUN , 50 (2) 77 - 81.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Boden, R; Begent, RH; (2001) A mouse model for calculating the absorbed beta-particle dose from (131)I- and (90)Y-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor. Radiat Res , 156 (1) pp. 28-35.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Boden, R; Begent, RHJ; (2001) A mouse model for calculating the absorbed beta-particle dose from I-131- and Y-90-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor. RADIAT RES , 156 (1) 28 - 35.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Boden, RAB; R, HJ; (2001) A mouse model for calculating the absorbed beta dose, from 131I and 90Y labelled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumour. Radiation Research , 156 pp. 28-35.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Begent, RH; (2001) Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images. Cancer Biother Radiopharm , 16 (5) pp. 391-400. 10.1089/108497801753354294.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Begent, RHJ; (2001) Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images. CANCER BIOTHER RADIO , 16 (5) 391 - 400.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Dearling, J; Bhatia, J; (2001) Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: A comparative study using the linear-quadratic formulation. International Journal of Radiation Biology , 77 (4) pp. 507-517. 10.1080/09553000010024902.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Dearling, J; Bhatia, J; (2001) Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation. INT J RADIAT BIOL , 77 (4) 507 - 517.

Furlanetto, A; Colombari, R; Capelli, P; Quaglia, A; Dhillon, AP; (2001) Inflammatory pseudotumor of the liver: A morphological and immunohistochemical study of 10 cases. J HEPATOL , 34 230 - 230.

G

Gambus, G; Bourboulia, D; Esteve, A; Lahoz, R; Rodriguez, C; Bolao, F; Sirera, G; (2001) Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain. AIDS , 15 (9) 1167 - 1174.

Gameiro, P; Vieira, S; Carrara, P; Silva, AL; Diamond, J; de Sousa, AB; Mehta, AB; (2001) The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients. Haematologica , 86 (6) 577 - 585. Green open access
file

Gary, J; (2001) Thalidomide brilliant at beating Lung Cancer. The Mirror 24-.

Geddes, JF; Hackshaw, AK; Vowles, GH; Nickols, CD; Whitwell, HL; (2001) Neuropathology of inflicted head injury in children I. Patterns of brain damage. BRAIN , 124 1290 - 1298.

Geddes, JF; Vowles, GH; Hackshaw, AK; Nickols, CD; Scott, IS; Whitwell, HL; (2001) Neuropathology of inflicted head injury in children II. Microscopic brain injury in infants. BRAIN , 124 1299 - 1306.

Gentry, CC; Okolo, SO; Fong, LFWT; Crow, JC; Maclean, AB; Perrett, CW; (2001) Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium. CLIN SCI , 101 (6) 691 - 695.

Gerrard, G; Ganeshaguru, K; Baker, R; Potter, M; Prentice, HG; Burgess, M; Herbert, L; (2001) A Phase 1 study of a P-gP inhibitor Zosuquidar (LY 335979), given by short intravenous infusion in combination with daunorubicin and cytarabine in AML/MDS patients. In: (pp. 177B-177B). AMER SOC HEMATOLOGY

Giannikaki, ES; Colombari, R; Dhillon, AP; (2001) Achieving accuracy in the diagnosis of disease. Defining the utility of biopsy, staging/grading and current issues in the interpretation of results. In: Dusheiko, G and Rosenberg, W and Miles, A, (eds.) The effective management of hepatitis C infection. (pp. 65-72). Aesculapius Medical Press: London.

Glassford, J; Holman, M; Banerji, L; Clayton, E; Klaus, GG; Turner, M; Lam, EW; (2001) Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen Receptor. Journal of Biological Chemistry , 276 (44) pp. 41040-41048. Gold open access

Goodchild, K; Hill, SA; Sibtain, A; Chaplin, DJ; Makris, A; (2001) Assessment of microregional blood flow in human breast carcinomas after administration of anthracycline chemotherapy. British Journal of Cancer , 85 p. 48.

Green, AJ; Baig, S; Begent, RHJ; (2001) Use of gadolinium-153 transmission attenuation maps for quantitative I-131SPECT with dual window scatter correction. European Journal of Nuclear Medicine , 28 (8) S131-.

Green, AJ; Baig, S; Begent, RHJ; CRC Targeting & Imaging Grp, ; (2001) Use of gadolinium-153 transmission attenuation maps for quantitative I-131SPECT with dual window scatter correction. EUR J NUCL MED , 28 (8) 1109 - 1109.

Green, AJ; Baig, S; Francis, RJ; Begent, RHJ; (2001) Semi quantitative analysis of F18-FDG imaging using a hybrid camera for the assessment of tumour response to therapy. European Journal of Nuclear Medicine , 28 (8) S132-.

Green, AJ; Baig, S; Francis, RJ; Begent, RHJ; CRC Targeting & Imaging Grp, ; (2001) Semi quantitative analysis of F18-FDG imaging using a hybrid camera for the assessment of tumour response to therapy. EUR J NUCL MED , 28 (8) 1109 - 1109.

Green, AJ; Johnson, CJ; Adamson, KL; Begent, RHJ; (2001) Mathematical model of antibody targeting: important parameters defined using clinical data. Physics in Medicine and Biology , 46 (6) pp. 1679-1693.

Green, AJ; Johnson, CJ; Adamson, KL; Begent, RHJ; (2001) Mathematical model of antibody targeting: important parameters defined using clinical data. PHYS MED BIOL , 46 (6) 1679 - 1693.

Gregson, SJ; Howard, PW; Hartley, JA; Brooks, NA; Adams, LJ; Jenkins, TC; Kelland, LR; (2001) Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity. J MED CHEM , 44 (5) 737 - 748. 10.1021/jm001064n.

Gricks, CS; Rawlings, E; Foroni, L; Madrigal, JA; Amlot, PA; (2001) Somatically mutated regions of immunoglobulin on human B cell lymphomas code for peptides that bind to autologous MHC Class I providing a potential target for cytotoxic T cells. Cancer Research , 61 (13) pp. 5145-5152.

Gricks, CS; Rawlings, E; Foroni, L; Madrigal, JA; Amlot, PL; (2001) Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells. CANCER RES , 61 (13) pp. 5145-5152.

Gricks, CS; Rawlings, E; Foroni, L; Madrigal, JA; Amlot, PL; (2001) Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells. Cancer Research , 61 (13) pp. 5145-5152.

Grote, D; Russell, SJ; Cattaneo, R; Vile, R; Fielding, A; (2001) Attenuated measles virus therapy for lymphoma. GENE THERAPY , 8 S6-S6.

Grote, D; Russell, SJ; Cornu, TI; Cattaneo, R; Vile, R; Poland, GA; Fielding, AK; (2001) Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. BLOOD , 97 (12) pp. 3746-3754. 10.1182/blood.V97.12.3746.

Guiducci, C; Cerone, MA; Bacchetti, S; (2001) Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability. Oncogene , 20 (6) pp. 714-725. 10.1038/sj.onc.1204145.

H

Hackshaw, AK; Wald, NJ; (2001) Assessment of the value of reporting partial screening results in prenatal screening for Down syndrome. PRENATAL DIAG , 21 (9) 737 - 740.

Hackshaw, AK; Wald, NJ; (2001) Inaccurate estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screening. PRENATAL DIAG , 21 (9) 741 - 746.

Hackshaw, AK; Wald, NJ; (2001) Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markers. PRENATAL DIAG , 21 (1) 58 - 61.

Hackshaw, AK; Wald, NJ; George, LM; (2001) Measuring serum markers once or twice in each assay in antenatal screening for Down syndrome and neural tube defects. PRENATAL DIAG , 21 (1) 72 - 72.

Hackshaw, AK; Wald, NJ; George, LM; (2001) Singleton versus duplicate assays in maternal serum screening - Reply. PRENATAL DIAG , 21 (10) 895 - 896.

Hadjur, S; Ung, K; Wadsworth, L; Dimmick, J; Rajcan-Separovic, E; Scott, RW; Buchwald, M; (2001) Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase. BLOOD , 98 (4) 1003 - 1011.

Hadjur, S; Ung, K; Wadsworth, LD; Dimmick, J; Scott, RW; Buchwald, M; Jirik, FR; (2001) Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase. BLOOD , 98 (11) 69A - 69A.

Hale, G; Cobbold, S; Novitzky, N; Bunjes, D; Willemze, R; Prentice, HG; Milligan, D; (2001) CAMPATH-1 antibodies in stem-cell transplantation. CYTOTHERAPY , 3 (3) 145 - 164.

Hames, RS; Wattam, SL; Yamano, H; Bacchieri, R; Fry, AM; (2001) APC/C-mediated destruction of the centrosomal kinase Nek2A occurs in early mitosis and depends upon a cyclin A-type D-box. EMBO J. , 20 (24) pp. 7117-7127.

Hancock, BW; Gregory, WM; Cullen, MH; Hudson, GV; Burton, A; Selby, P; Maclennan, KA; (2001) ChlVPP alternating with PABIOE is superior to PABIOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial. BRIT J CANCER , 84 (10) 1293 - 1300. 10.1054/bjoc.2001.1778.

Hardy, SJ; Shah, SK; Pizzey, A; Khwaja, A; Yong, KL; (2001) Monocytes rescue endothelial cells from apoptosis: Role of nuclear factor kappa B (NF-kappa B). BLOOD , 98 (11) 16A - 16A.

Harris, E; Mahendra, P; McGarrigle, HH; Linch, DC; Chatterjee, R; (2001) Gynaecomastia with hypergonadotrophic hypogonadism and Leydig cell insufficiency in recipients of high-dose chemotherapy or chemoradiotherapy. BONE MARROW TRANSPL , 28 (12) 1141 - 1144.

Hartley, JA; (2001) Alkylating agents. In: Souhami, RL and Tannock, IF and Hohenberger, P and Horiot, JC, (eds.) Oxford Textbook of Oncology. (pp. 639-654).

Hartley, JC; Kaye, S; Stevenson, S; Bennett, J; Ridgway, G; (2001) PCR detection and molecular identification of Chlamydiaceae species. JOURNAL OF CLINICAL MICROBIOLOGY , 39 (9) pp. 3072-3079. 10.1128/JCM.39.9.3072-3079.2001.

Hennessy, B; North, J; Deru, A; Llewellyn-Smith, N; Lowdell, MW; (2001) Use of Leu3a/3b for the accurate determination of CD4 subsets for measurement of intracellular cytokines. CYTOMETRY , 44 (2) 148 - 152.

Hennessy, BJ; Orchard, KH; Potter, MN; (2001) Novel approaches to transplant conditioning. HEMATOL ONCOL , 19 (2) 43 - 57.

Hercus, B; Revell, PA; (2001) Phenotypic characteristics of T lymphocytes in the interfacial tissue of aseptically loosened prosthetic joints. Journal of Materials Science: Materials in Medicine , 12 (10-12) pp. 1063-1067.

Herrero, J; Valencia, A; Dopazo, J; (2001) A hierarchical unsupervised growing neural network for clustering gene expression patterns. BIOINFORMATICS , 17 (2) pp. 126-136. 10.1093/bioinformatics/17.2.126.

Herreros, J; Ng, T; Schiavo, G; (2001) Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons. Mol Biol Cell , 12 (10) pp. 2947-2960.

Hollrigl, A; Hergovich, A; Gorzer, I; Bader, A; Ellersdorfer, G; Habegger, K; Hammer, E; (2001) High-throughput site-directed mutagenesis in ES cells. BIOCHEM BIOPH RES CO , 289 (2) 329 - 336.

Horton, MA; Seligsohn, U; Massey, HM; Flanagan, AM; (2001) Upregulation of alpha 2 beta 1 integrin in beta 3 null type Glanzmann Thrombasthenia enables bone resorption. JOURNAL OF BONE AND MINERAL RESEARCH , 16 S154-S154.

Hoskin, PJ; Chow, EL; Wu, J; Coia, L; (2001) Uncertainties in the measurement of metastatic bone pain. In: (pp. S5-).

Hoskin, PJ; Dickson, J; (2001) Clincal uncertainties in the use of radical nodal irradiation in Hodgkins disease. In: (pp. S3-).

Hoskin, PJ; Dickson, J; (2001) Survival and morbidity after post operative vaginal va. In: (pp. 90-).

Hoskin, PJ; Yarnold, JR; Roos, DR; Bentzen, S; (2001) Radiotherapy for bone metastases. Clinical Oncology , 13 (2) pp. 88-90.

Howie, AJ; Ferreira, MAS; Adu, D; (2001) Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrology Dialysis Transplantation , 16 (6) pp. 1163-1169.

Hughes, AN; Lind, M; Azzabi, A; Todd, R; Plummer, R; Margetts, J; Fishwick, K; (2001) A phase I dose escalation study of doxorubicin in combination with pemetrexed (Alimta (R), multitargeted antifolate). BREAST CANCER RES TR , 69 (3) 286 - 286.

Huntly, BJP; Bench, AJ; Reid, AG; Nacheva, EP; Byrne, J; Brizzard, A; Niederweiser, D; (2001) Lack of expression of the ABL-BCR transcript is not always associated with deletion of the derivative chromosome 9 and does not explain the poor prognosis associated with these deletions in CML. BLOOD , 98 (11) 260B - 260B.

Huntly, BJP; Reid, AG; Bench, AJ; Campbell, LJ; Telford, N; Shepherd, P; Szer, J; (2001) Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. BLOOD , 98 (6) 1732 - 1738. Green open access
file

I

ITN, NLSIBRB; (2001) Thalidomide: new use for drug. UNSPECIFIED

J

Jackson, G; Taylor, P; Smith, GM; Marcus, R; Smith, A; Chu, P; Littlewood, TJ; (2001) A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation. BRITISH JOURNAL OF HAEMATOLOGY , 112 (1) pp. 127-137. 10.1046/j.1365-2141.2001.02551.x.

Jacqui Thornton, MR; (2001) Can the drug which did this cure cancer? Thalidomide shrinks tumours. The Sun 39-.

James, M; (2001) Thalidomide may fight cancer. Independent

James, M; (2001) Thalidomide may fight cancer. Tablets that caused horrific birth defects thought to help shrink tumours. The Guardian 2-.

Jansen, S; Pearson, T; Morgan, NV; Tipping, AJ; Kuyt, LP; Mathew, CG; (2001) The genealogy of Fanconi Anaemia patients homozygotic for the type I and type II Afrikaner mutations. AM J HUM GENET , 69 (4) 397 - 397.

Jaswon, MS; Linch, DC; (2001) Priming of neutrophil function in the newborn. BRIT J HAEMATOL , 113 (4) 1078 - 1079.

Javed, MS; Harrison, E; Gillams, A; Amin, A; Ledermann, J; Lees, W; Taylor, I; (2001) The multimodal treatment of colorectal liver metastases. In: BRIT J SURG. (pp. 68 - 68). BLACKWELL SCIENCE LTD

Jenner, RG; Alba, MM; Boshoff, C; Kellam, P; (2001) Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J VIROL , 75 (2) 891 - 902.

Jennings, SA; Toth, JL; Roller, SG; Brooks, N; O'Hare, C; Kiakos, K; Hartley, JA; (2001) Efficient synthesis of (+/-)-seco-cyclopropaneindoline analogs of CC-1065. HETEROCYCL COMMUN , 7 (1) 7 - 16.

Jenny, H; (2001) Thalidomide therapy. Disgraced drug offers hope in lung cancer fight. Daily Mail 39-.

Jeremy, L; (2001) Thalidomide is used to treat lung cancer. The Independent

Jo, H; (2001) Thalidomide hope for Cancer. GP Magazine 33-.

John, C; (2001) Thalidomide for cancer victims. Daily Express

Jones, DT; Ganeshaguru, K; Virchis, AE; Folarin, NI; Lowdell, MW; Mehta, AB; Prentice, HG; (2001) Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation. BLOOD , 98 (9) 2800 - 2807.

Jones, DT; Ganeshaguru, K; Virchis, AE; Folarin, NI; Lowdell, MW; Mehta, AB; Prentice, HG; (2001) Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation. Blood , 98 (9) pp. 2800-2807. Green open access
file

Jooss, K; Gjata, B; Danos, O; von Boehmer, H; Sarukhan, A; (2001) Regulatory function of in vivo anergized CD4(+) T cells. Proc Natl Acad Sci U S A , 98 (15) pp. 8738-8743. 10.1073/pnas.151088898.

Joseph, JE; Harrison, P; Mackie, IJ; Isenberg, DA; Machin, SJ; (2001) Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. British Journal of Haematology , 115 (2) pp. 451-459. 10.1046/j.1365-2141.2001.03101.x.

Joseph, JE; Harrison, P; Mackie, IJ; Isenberg, DA; Machin, SJ; (2001) Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. BRIT J HAEMATOL , 115 (2) 451 - 459.

Joshi, CV; Gale, KB; Thykjaer, TA; Orntoft, T; Enver, T; (2001) GATA-2-dependent modulation of transcriptional profiles in hematopoietic progenitor cells. BLOOD , 98 (11) 551A-552A.

K

Kaufman, J; Bumstead, N; Butter, C; Davison, TF; Jacob, J; Johnston, F; Milne, S; (2001) Coevolution in the chicken MHC: Polymorphic taps and shallow grooves. In: Schat, KA, (ed.) CURRENT PROGRESS ON AVIAN IMMUNOLOGY RESEARCH, PROCEEDINGS. (pp. 162 - 162). AMER ASSOC AVIAN PATHOLOGISTS INC

Kayyali, R; Porter, JB; Liu, ZD; Davies, NA; Nugent, JH; Cooper, CE; Hider, RC; (2001) Structure-function investigation of the interaction of 1-and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase. J BIOL CHEM , 276 (52) 48814 - 48822. 10.1074/jbc.M109551200. Gold open access

Kelly, PF; Carrington, J; Nathwani, A; Vanin, EF; (2001) RD114-pseudotyped oncoretroviral vectors biological and physical properties. HEMATOPOIETIC STEM CELLS 2000 BASIC AND CLINICAL SCIENCES , 938 262 - 277.

Kenny, PA; Danielian, PS; Dale, TC; Enver, T; Ashworth, A; (2001) Identification of novel Wnt-1/beta-catenin target genes in mouse mammary epithelial cells. MOLECULAR BIOLOGY OF THE CELL , 12 100A-100A.

Keshtgar, M; Lee, A; Taylor, I; Davidson, T; Ell, PJ; Ralphs, D; Kocjan, G; (2001) The role of intraoperative imprint cytology in determining the histological status of the sentinel lymph node. BRIT J SURG , 88 32 - 32.

Kiakos, K; Brooks, N; Hartley, JA; Toth, J; Lee, M; (2001) Design, synthesis,cytotoxicity and sequence specificity of N-methylpyrrole C-and N-terminus linked seco-cyclopropylindole hybrid molecules. In: (pp. 1374-).

Kiakos, K; Brooks, N; McHugh, PJ; Loward, T; Lee, M; Hartley, JA; (2001) Repair of seqence specific adenine-N3 alkylations in the minor groove of DNA. In: (pp. 3737-).

King, M; Vinall, LE; Novelli, M; Sarner, M; Swallow, DM; (2001) MUC1 in Helicobacter gastritis. In: GASTROENTEROLOGY. (pp. A670 - A670). W B SAUNDERS CO

Kocjan, G; (2001) Clinical Cytopathology of the Head and Neck: a Text and Atlas. [Book]. (1 vols). (1 ed.). Greenwich Medical Media, now Cambridge University Press: London.

Kocjan, G; Miller, R; (2001) The cytology of HIV-induced immunosuppression. Changing pattern of disease in the era of highly active antiretroviral therapy. CYTOPATHOLOGY , 12 (5) 281 - 296.

Kottaridis, P; Milligan, D; Chopra, R; Craddock, C; Mahendra, P; Hunter, A; Marsh, J; (2001) A non-myeloablative regimen with minimal non relapse mortality for allografting patients with Hodgkin's disease. BONE MARROW TRANSPLANTATION , 27 S66-S66.

Kottaridis, PD; Gale, RE; Frew, ME; Harrison, G; Langabeer, SE; Belton, AA; Walker, H; (2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. BLOOD , 98 (6) 1752 - 1759.

Kottaridis, PD; Gale, RE; Langabeer, SE; Linch, DC; (2001) Changes in the pattern of FLT3 mutations between diagnosis and relapse restricts their potential use as markers of minimal residual disease in patients with acute myeloid leukaemia. BLOOD , 98 (11) 717A - 718A.

Kottaridis, PD; Milligan, DW; Chopra, R; Chakraverty, RK; Chakrabarti, S; Robinson, S; Peggs, K; (2001) In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation. CYTOTHERAPY , 3 (3) 197 - 201.

Kottaridis, PD; Milligan, DW; Chopra, R; Craddock, C; Kyriacou, C; Peggs, K; Cakrabati, S; (2001) Non-myeloablative transplantation for patients with Hodgkin's disease: Limited transplant related mortality and possible evidence of a graft versus Hodgkin's effect. In: BLOOD. (pp. 416A - 416A). AMER SOC HEMATOLOGY

Kushner, JP; Porter, JP; Olivieri, NF; (2001) Secondary iron overload. Hematology Am Soc Hematol Educ Program pp. 47-61.

Kyriakou, CA; Milligan, D; Chopra, R; Craddock, C; Chakraverty, R; Mahendra, P; Pettengell, R; (2001) Outcome of non-myeloablative stem cell transplantation for NHL is dependent on histology: Good for patients with low grade disease and poor for those with high grade lymphoma. In: BLOOD. (pp. 414A - 414A). AMER SOC HEMATOLOGY

L

LEDERMANN, J; (2001) Relapse with ascites within 12 months of diagnosis. In: Ledermann, JA and Hoskins, WJ and Kaye, SB, (eds.) Clinical management of ovarian cancer. (pp. 147-158). Informa HealthCare: London UK.

Lader, CS; Scopes, J; Horton, MA; Flanagan, AM; (2001) Generation of human osteoclasts in stromal cell-free and stromal cell-rich cultures: differences in osteoclast CD11c/CD18 integrin expression. BRIT J HAEMATOL , 112 (2) 430 - 437.

Laman, H; Boshoff, C; (2001) Is KSHV lytic growth induced by a methylation-sensitive switch? TRENDS MICROBIOL , 9 (10) 464 - 466.

Lander, ES; Linton, LM; Birren, B; Nusbaum, C; Zody, MC; Baldwin, J; Devon, K; (2001) Initial sequencing and analysis of the human genome. NATURE , 409 (6822) 860 - 921.

Langabeer, SE; Rogers, JR; Harrison, G; Wheatley, K; Walker, H; Bain, BJ; Burnett, AK; (2001) EVI1 expression in acute myeloid leukaemia. BRIT J HAEMATOL , 112 (1) 208 - 211.

Laurenzi, M; Tipping, AJ; Marcus, SE; Knox, JP; Federico, R; Angelini, R; McPherson, MJ; (2001) Analysis of the distribution of copper amine oxidase in cell walls of legume seedlings. PLANTA , 214 (1) 37 - 45.

Lawrie, AS; Mackie, IJ; Purdy, G; Machin, SJ; (2001) Effect of lupus anticoagulants on INR with different thromboplastins. BLOOD COAGUL FIBRIN , 12 (3) 221 - 221.

Ledermann, JA; Herd, R; Maraninchi, D; Viens, P; Buclon, M; Philip, T; Cure, H; (2001) High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT). ANN ONCOL , 12 (5) 693 - 699.

Ledermann, JA; Leonard, P; Seymour, M; (2001) Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. NEW ENGL J MED , 345 (2) 145 - 146.

Lerner, B; Clocksin, WF; Dhanjal, S; Hulten, MA; Bishop, CM; (2001) Automatic signal classification in fluorescence in situ hybridization images. CYTOMETRY , 43 (2) 87 - 93.

Lerner, B; Clocksin, WF; Dhanjal, S; Hulten, MA; Bishop, CM; (2001) Feature representation and signal classification in fluorescence in-situ hybridization image analysis. IEEE T SYST MAN CY A , 31 (6) 655 - 665.

Lerner, B; Dhanjal, S; Hulten, MA; (2001) GELFISH - Graphical environment for labelling fluorescence in-situ hybridization images. J MICROSC-OXFORD , 203 258 - 268.

Levine, TS; Rolfe, KJ; Crow, J; Styles, S; Perrett, CW; MacLean, AB; Reid, WMN; (2001) The use of cytospin monolayer technique in the cytological diagnosis of vulval and anal disease. CYTOPATHOLOGY , 12 (5) 297 - 305.

Liatsos, C; Mehta, AB; Potter, M; Burroughs, AK; (2001) The hepatologist in the haematologists' camp. Br J Haematol , 113 (3) pp. 567-578.

Little, AM; Cox, ST; Hoddinott, MA; Ogilvie, H; Bohan, EM; Mufti, GJ; Madrigal, JA; (2001) Identification of HLA-B*0722. Tissue Antigens , 57 (2) pp. 167-168.

Little, AM; Cox, ST; Hoddinott, MA; Ogilvie, H; Bohan, EM; Mufti, GJ; Madrigal, JA; (2001) Identification of HLA-B*0722. Tissue Antigens , 57 (2) pp. 167-168.

Little, AM; Scott, I; Pesoa, S; Marsh, SGE; Arguello, R; Cox, ST; Ramon, D; (2001) HLA class I diversity in Kolla Amerindians. HUMAN IMMUNOLOGY , 62 (2) pp. 170-179. 10.1016/S0198-8859(00)00248-2.

Love, EM; Jones, H; Williamson, EM; Cohen, H; (2001) The 1999/2000 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Low, W; Harries, M; Ye, HT; Du, MQ; Boshoff, C; Collins, M; (2001) Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein. J VIROL , 75 (6) 2938 - 2945.

Lowdell, MW; (2001) Allogeneic immunotherapy of acute leukaemia. CME Bulletin Haematology , 3 (3) pp. 63-66.

Lowdell, MW; (2001) Data analysis in flow cytometry. In: McCarthy, D and Macey, MG, (eds.) Cytometric Analysis of Cell Phenotype and Function. Cambridge University Press: Cambridge.

Lowdell, MW; Lamb, L; Hoyle, C; Velardi, A; Prentice, HG; (2001) Non-MHC-restricted cytotoxic cells: Their roles in the control and treatment of leukaemias. BRIT J HAEMATOL , 114 (1) 11 - 24.

Luzzatto, L; Mehta, AB; Vulliamy, T; (2001) Glucose-6-phosphate Dehydrogenase Deficiency. Metabolic and Molecular Basics of Inherited Disease. In: Scriver, CR and Beaudet, AL and Sly, WS and Valle, D, (eds.) The Metabolic & Molecular Bases of Inherited Diseases. (pp. 4517-4554).

M

Mackie, IJ; Piegsa, K; Furs, SA; Johnson, J; Bounds, W; Machin, SJ; Guillebaud, J; (2001) Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over. BRIT J HAEMATOL , 113 (4) 898 - 904.

Maclean, KH; Cleveland, JL; Porter, JB; (2001) Cellular zinc content is a major determinant of iron chelator-induced apoptosis of thymocytes. BLOOD , 98 (13) 3831 - 3839.

Mainwaring, P.N.; Cunningham, D.; Gregory, W.; Hoskin, P.; Hancock, B.; Norton, A.J.; MacLennan, K.; (2001) Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO. Blood , 97 (10) pp. 2991-2997. 10.1182/blood.V97.10.2991. Green open access
file

Mainwaring, PN; Cunningham, D; Gregory, W; Hoskin, P; Hancock, B; Norton, AJ; MacLennan, K; (2001) Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO. Blood , 15 (97) pp. 2991-2997.

Mainwaring, PN; Cunningham, D; Gregory, W; Hoskin, P; Hancock, B; Norton, AJ; MacLennan, K; (2001) Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO. Blood , 97 (10) pp. 2991-2997.

Makris, A; Burcombe, RJ; Cladd, H; Smith, JM; Makris, M; (2001) Raised plasma homocysteine levels in women with metastatic breast cancer. British Journal of Cancer , 85 p. 26.

Mallett, SV; Peachey, TD; Sanehi, O; Hazelhurst, G; Mehta, A; (2001) A reducing red blood cell transfusion in elective surgical patients: the role of audit and practice guidelines. Anaesthesia , 55 pp. 1003-1024.

Marchant, WA; Wright, S; Porter, JB; (2001) Coronary artery bypass graft surgery in a patient with haemoglobin SC disease. Anaesthesia , 56 (7) pp. 667-669.

Marks, AJ; Cooper, M; Orchard, K; Prentice, HG; Mehta, AB; Hales, G; Wickremasinghe, RG; (2001) Selective killing of leukemia cell lines by antibody-mediated targeting of a cytotoxic amphipathic peptide. BLOOD , 98 (11) 721A - 721A.

Marsh, SG; (2001) Nomenclature for factors of the HLA System, update February 2001. Eur J Immunogenet , 28 (4) pp. 463-464.

Marsh, SG; (2001) Nomenclature for factors of the HLA System, update March 2001. Eur J Immunogenet , 28 (4) 465-.

Marsh, SG; (2001) Nomenclature for factors of the HLA system, update December 2000. Tissue Antigens , 57 (2) pp. 180-183.

Marsh, SG; (2001) Nomenclature for factors of the HLA system, update January 2001. Tissue Antigens , 57 (4) pp. 394-395.

Marsh, SG; (2001) Nomenclature for factors of the HLA system, update November 2000. Tissue Antigens , 57 (2) pp. 177-179.

Marsh, SG; Bodmer, JG; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; (2001) Nomenclature for factors of the HLA system, 2000. Hum Immunol , 62 (4) pp. 419-468.

Marsh, SG; Bodmer, JG; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; (2001) Nomenclature for factors of the HLA system, 2000. Tissue Antigens , 57 (3) pp. 236-283.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update April 2001. Tissue Antigens , 58 (3) pp. 207-208.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update August 2001. Hum Immunol , 62 (12) pp. 1382-1383.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update February 2001. Tissue Antigens , 57 (6) pp. 551-552.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update July 2001. Tissue Antigens , 58 (4) pp. 278-279.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update June 2001. Hum Immunol , 62 (10) pp. 1187-1188.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update June 2001. Tissue Antigens , 58 (4) pp. 276-277.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update March 2001. Tissue Antigens , 57 (6) pp. 553-554.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update May 2001. Hum Immunol , 62 (10) pp. 1185-1186.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update May 2001. Tissue Antigens , 58 (3) pp. 209-210.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update October 2000. Tissue Antigens , 57 (1) pp. 93-94.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA system, ; (2001) Nomenclature for factors of the HLA system, update September 2001. Hum Immunol , 62 (12) 1384-.

Marsh, SG; WHO Nomenclature Committee for factors of the HLA system, ; (2001) Nomenclature for factors of the HLA system, Update December 2000. Hum Immunol , 62 (3) pp. 294-296.

Marsh, SG; WHO Nomenclature Committee for factors of the HLA system, ; (2001) Nomenclature for factors of the HLA system, Update November 2000. Hum Immunol , 62 (3) pp. 292-293.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update April 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (5) p. 557. 10.1046/j.1365-2370.2001.00295.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update August 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (1) pp. 101-102. 10.1046/j.1365-2370.2001.00255.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update August 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (6) pp. 599-600. 10.1046/j.1365-2370.2001.00306.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update December 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (2) pp. 191-193.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update January 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (3) pp. 439-440. 10.1046/j.1365-2370.2001.00278.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update July 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (6) p. 597. 10.1046/j.1365-2370.2001.00298.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update June 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (5) p. 561. 10.1046/j.1365-2370.2001.00297.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update May 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (5) p. 559. 10.1046/j.1365-2370.2001.00296.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update November 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (2) pp. 189-190.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update October 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (2) pp. 187-188. 10.1046/j.1365-2370.2001.00257.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update September 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (1) p. 103. 10.1046/j.1365-2370.2001.00256.x.

Marsh, SGE; Bodmer, JG; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, S; Erlich, HA; (2001) Nomenclature for factors of the HLA system, 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (3) pp. 377-424. 10.1046/j.1365-2370.2001.00268.x.

Massey, HM; Horton, MA; Flanagan, AM; (2001) Macrophage-deactivating molecules, transforming growth factor beta(1) (TGF-beta), interleukin (IL)-4 and IL-13 stimulate the osteoclast-forming potential of peripheral blood haemopoietic precursors in a lymphocyte-rich microenvironment. BONE , 28 (5) S160-S160.

Massey, HM; Steward, CG; Wilson, C; Vellodi, A; Horton, MA; Flanagan, AM; (2001) Recombinant human RANK ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) fail to rescue human infantile osteoclast-poor osteopetrosis (OP) in vitro. BONE , 28 (5) S114 - S114.

Maxwell-Armstrong, CA; Durrant, LG; Buckley, TJD; Scholefield, JH; Robins, RA; Fielding, K; Monson, JRT; (2001) Randomized double-blind phase II survival study comparing immunization with the anti idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer. BRIT J CANCER , 84 (11) 1443 - 1446.

McCloskey, KE; Zborowski, M; Chalmers, JJ; (2001) Measurement of CD2 expression levels of IFN-alpha-treated fibrosarcomas using cell tracking velocimetry. Cytometry , 44 (2) pp. 137-147.

McGurk, CJ; McHugh, PJ; Tilby, MJ; Grimaldi, KA; Hartley, JA; (2001) Measurement of covalent drug-DNA interactions at the nucleotide level in cells at pharmacologically relevant doses. METHOD ENZYMOL , 340 358 - 376.

McHugh, PJ; Spanswick, VJ; Hartley, JA; (2001) Repair of DNA interstrand crosslinks molecular mechanisms and clinical relevance. The Lancet Oncology , 2 pp. 483-490.

McHugh, PJ; Spanswick, VJ; Hartley, JA; (2001) Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol , 2 (8) pp. 483-490. 10.1016/S1470-2045(01)00454-5.

Mehta, A; Guidelines, C; (2001) Diagnosis and management of myeloma. British Journal of Haematology , 115 pp. 522-540.

Mehta, AB; (2001) Anaemia. In: Bloom, SL, (ed.) Practical Gastroenterology. (pp. 321-330). Martin Dunitz Ltd

Mehta, AB; Burroughs, AK; (2001) Thrombopoietin concentration after orthotopic liver transplantation. British Journal of Haematology , 114 (4) pp. 960-961.

Mehta, AB; Hennessy, B; (2001) Gastrointestinal problems in haematological patients. In: Bloom, SL, (ed.) Practical Gastroenterology. (pp. 55-70). Martin Dunitz Ltd

Mehta, ABBAK; (2001) Thrombopoietin concentration after orthotopic liver. British Journal of Haematology , 114 (4) pp. 960-961.

Meng, MV; Grossfeld, GD; Williams, GH; Dilworth, S; Stoeber, K; Mulley, TW; Weinberg, V; (2001) Minichromosome maintenance protein 2 expression in prostate: Characterization and association with outcome after therapy for cancer. CLIN CANCER RES , 7 (9) 2712 - 2718.

Meyer, T; Cole, LA; Richman, PI; Mitchell, HD; Myers, J; Rustin, GJ; (2001) High levels of hCG in choriocarcinoma can result in renal failure and a false-negative pregnancy test in men. Clin Oncol (R Coll Radiol) , 13 (4) pp. 301-303.

Meyer, T; Davidson, B; Hochhauser, D; Dhillon, P; Begent, R; (2001) Fibrolamellar Carcinoma: a Strategy for Management. In: (Proceedings) ASCO General Meeting. (pp. 2311-).

Meyer, T; Nelstrop, AE; Mahmoudi, M; Rustin, GJ; (2001) Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer. Ann Oncol , 12 (12) pp. 1705-1709.

Miles, DW; Smith, IE; Coleman, RE; Calvert, AH; Lind, MJ; (2001) A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancer. EUR J CANCER , 37 (11) 1366 - 1371.

Mobasheri, A; Oukrif, D; Dawodu, SP; Sinha, M; Greenwell, P; Stewart, D; Djamgoz, MBA; (2001) Isoforms of Na+, K+-ATPase in human prostate; specificity of expression and apical membrane polarization. HISTOL HISTOPATHOL , 16 (1) 141 - 154.

Mollapour, E; Linch, DC; Roberts, PJ; (2001) Activation and priming of neutrophil nicotinamide adenine dinucleotide phosphate oxidase and phospholipase A(2) are dissociated by inhibitors of the kinases p42(ERK2) and p38(SAPK) and by methyl arachidonyl fluorophosphonate, the dual inhibitor of cytosol. Blood , 97 (8) pp. 2469-2477.

Mollapour, E; Linch, DC; Roberts, PJ; (2001) Activation and priming of neutrophil nicotinamide adenine dinucleotide phosphate oxidase and phospholipase A(2) are dissociated by inhibitors of the kinases p42(ERK2) and p38(SAPK) and by methyl arachidonyl fluorophosphonate, the dual inhibitor of cytosolic and calcium-independent phospholipase A(2). BLOOD , 97 (8) 2469 - 2477.

Moreira, I; Papaionnou, M; Mortuza, FY; Gameiro, P; Palmisano, GL; Swanton, S; Harrison, CJ; (2001) Oligoclonality: an insight into the biology of acute lymphoblastic leukaemia. Leukemia , 15 (10) pp. 1527-1533.

Morris, E; Naik, P; Goldstone, A; Linch, D; Mackinnon, S; Singer, M; (2001) 5 year experience of intensive care for critically ill patients following chemotherapy or bone marrow transplantation: Who should go to ICU? BLOOD , 98 (11) 432A - 433A.

Morris, E; Rebello, P; Thomson, K; Peggs, K; Kyriakou, C; Goldstone, A; Linch, D; (2001) Pharmacokinetics of Campath-1H in vivo T cell depletion in non-myeloablative allogeneic transplants: Relevance for early adoptive immunotherapy. In: BLOOD. (pp. 478A - 478A). AMER SOC HEMATOLOGY

Mortuza, FY; Moreira, IM; Papaioannou, M; Gameiro, P; Coyle, LA; Gricks, CS; Amlot, P; (2001) Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of J(H)-proximal variable gene segments. BLOOD , 97 (9) pp. 2716-2726. 10.1182/blood.V97.9.2716.

Mulatero, CW; Penson, RT; Papamichael, D; Gower, NH; Evans, MT; Rudd, RM; (2001) 'A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma'. Lung Cancer , 31 pp. 67-72.

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (2001) Flow cytometric method for simultaneous assay of foetal haemoglobin containing red cells, reticulocytes and foetal haemoglobin containing reticulocytes. CLIN LAB HAEMATOL , 23 (3) 149 - 154.

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (2001) Technical Report: Triple-Colour Staining Flow Cytometry for Co-Distribution of Thrombospondin Receptor (CD36), Ribonucleic Acid (RNA) and Fetal Haemoglobin (HbF) in Sickle Red Blood Cells. Hematology , 6 (1) pp. 91-100. 10.1080/10245332.2001.11746558.

Murphy, MF; Wallington, TB; Kelsey, P; Boulton, F; Bruce, M; Cohen, H; Duguid, J; (2001) Guidelines for the clinical use of red cell transfusions. British journal of haematology , 113 pp. 24-31.

N

Nagral, A; Quaglia, A; Sabin, CA; Dhillon, AP; Bearcroft, CP; Millar, A; Davies, SE; (2001) Blood and graft eosinophils in acute cellular rejection of liver allografts. TRANSPLANTATION PROCEEDINGS , 33 (4) 2588 - 2593.

Nathan, PD; Walker, D; Bridle, H; Ross, A; Stevenson, A; Lee, SM; Eisen, TG; (2001) A phase II study investigating the use of thalidomide in conjunction with interferon-alpha in patients with metastatic renal cell carcinoma. In: (Proceedings) 2001 ASCO Annual Meeting/37th Annual Meeting, San Francisco, California.. (pp. 265a-). Proceedings of the American Society of Clinical Oncology

Nathwani, AC; Davidoff, A; Hanawa, H; Zhou, JF; Vanin, EF; Nienhuis, AW; (2001) Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. Blood , 97 (5) pp. 1258-1265. Green open access
file

Ndisang, D; Budhram-Mahadeo, V; Pedley, RBAL; D, S; (2001) The Brn-3a transcription factor plays a key role in regulating the growth of cervical cells in vivo. Oncogene , 20 pp. 4899-4903.

New, HV; Harrison, CN; Rodeck, CH; de Silva, M; Cohen, H; (2001) Antenatal antibody screening. LANCET , 357 (9264) 1295 - 1295.

Nieto, JJ; Crow, J; Sundaresan, M; Constantinovici, N; Perrett, CW; MacLean, AB; Hardiman, PJ; (2001) Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity. GYNECOL ONCOL , 82 (2) 344 - 349. 10.1006/gyno.2001.6227.

Nigel, H; (2001) Thalidomide returns in lung cancer battle. The Times 12-.

Nikitenko, LL; Brown, NS; Smith, DM; MacKenzie, IZ; Bicknell, R; Rees, MCP; (2001) Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus. MOL HUM REPROD , 7 (7) 655 - 664.

Nitu-Whalley, IC; Griffioen, A; Harrington, C; Lee, CA; (2001) Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease. AM J HEMATOL , 66 (4) 280 - 284.

Nutting, C; Short, S; (2001) Where now with training in clinical oncology? Clinical Oncology , 13 pp. 4-5.

O

O'Connor, DL; Hall, R; Adamkin, D; Auestad, N; Castillo, M; Connor, WE; Connor, SL; (2001) Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics , 108 (2) pp. 359-371.

O'Nions, J; Brooks, LA; Sullivan, A; Bell, A; Dunne, B; Rozycka, M; Reddy, A; (2001) p73 is over-expressed in vulval cancer principally as the Delta 2 isoform. Br J Cancer , 85 (10) pp. 1551-1556. 10.1054/bjoc.2001.2138.

Okkenhaug, K; Vanhaesebroeck, B; (2001) New responsibilities for the PI3K regulatory subunit p85 alpha. Sci STKE , 2001 (65) pe1-. 10.1126/stke.2001.65.pe1.

Orleans-Lindsay, JK; Barber, LD; Prentice, HG; Lowdell, MW; (2001) Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function - implications for the adoptive immunotherapy of leukaemia. CLIN EXP IMMUNOL , 126 (3) 403 - 411.

Osborne, M; Makris, A; Hoskin, PJ; Lowe, J; Emmott, J; Wong, WL; (2001) The role of FDG whole body positron emission tomography in metastatic carcinoma of unknown primary site. British Journal of Cancer , 85 p. 90.

Osborne, M; Shah, N; Hoskin, PJ; Powell, MG; Anthony-Pillau, R; Glynne-Jones, R; Makris, A; (2001) Low dose folinic acid with infusional and bolus 5fluorouracil in advanced colorectal carcinoma. British Journal of Cancer , 85 p. 44.

Osborne, ME; Brown, RSD; Hoskin, PJ; (2001) Interaction of bisphosphonates with calcitonin in monitoring medullary carcinoma of the thyroid. Clinical Oncology , 13 (5) pp. 370-371.

P

Papatheodoridis, GV; Davies, S; Dhillon, AP; Teixeira, R; Goulis, J; Davidson, B; Rolles, K; (2001) The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis. TRANSPLANTATION , 72 (3) 412 - 418.

Parkinson, MC; Harland, SJ; Harnden, P; Sandison, A; (2001) The role of the histopathologist in the management of testicular germ cell tumour in adults. HISTOPATHOLOGY , 38 (3) 183 - 194.

Pay, AL; Little, AM; Madrigal, JA; (2001) Donor selection in allogeneic bone marrow transplantation. In: Carella, AG and Daley, GQ and Eaves, CJ and Goldman, JM and Hehlmann, R, (eds.) Chronic Myeloid Leukaemia Biology and Treatment. (pp. 421-250). Martin Dunitz Ltd: London.

Pay, AL; Little, AM; Madrigal, JA; (2001) Donor selection in allogeneic bone marrow transplantation. In: Carella, AG and Daley, GQ and Eaves, CJ and Goldman, JM and Hehlmann, R, (eds.) Chronic Myeloid Leukaemia Biology and Treatment. (pp. 421-250). Martin Dunitz Ltd: London.

Pedley, R.B.; Hill, S.A.; Boxer, G.M.; Flynn, A.A.; Boden, R.; Watson, R.; Dearling, J.; (2001) Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin A-4 3-O-phosphate. Cancer Research , 61 (12) pp. 4716-4722.

Pedley, RB; Flynn, AA; Dearling, J; Watson, R; Boxer, G; Boden, R; Hill, SA; (2001) Overcoming the problem of tumour heterogeneity by combined, regios-specific therapies. In: (pp. 871-).

Pedley, RB; Flynn, AA; Dearling, J; Watson, R; Boxer, GM; Boden, R; Hill, SA; (2001) Overcoming the problem of tumour heterogeneity by combined, region-specific therapies. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 871-).

Pedley, RB; Hill, SA; Boxer, GM; Flynn, AA; Boden, R; Watson, R; Dearling, J; (2001) Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin A-4 3-O-phosphate. CANCER RES , 61 (12) 4716 - 4722.

Peggs, K; Craddock, C; Milligan, D; Chopra, R; Mahendra, P; Chakraverty, R; Hunter, A; (2001) Non-myeloablative allogeneic transplantation for high-risk acute leukemia and myelodysplasia. In: BLOOD. (pp. 410A - 411A). AMER SOC HEMATOLOGY

Peggs, K; D'Sa, S; Kyriacou, C; Thuraisundaram, D; Williams, C; Goldstone, A; Mackinnon, S; (2001) Non-myeloablative allogeneic transplantation as front-line treatment for multiple myeloma: Response rates to conditioning and subsequent donor lymphocyte infusions. In: BLOOD. (pp. 419A - 419A). AMER SOC HEMATOLOGY

Peggs, K; Kottaridis, P; Morris, E; Kyriacou, C; Geary, J; Yong, K; Goldstone, A; (2001) Escalating dose donor lymphocyte infusions following non-myeloablative allogeneic transplantation are associated with minimal toxicity with sibling donors but a significant risk of severe GVHD with unrelated donors. In: BLOOD. (pp. 672A - 672A). AMER SOC HEMATOLOGY

Peggs, K; Verfuerth, S; Mackinnon, S; (2001) Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions. BLOOD , 97 (4) 994 - 1000.

Peggs, K; Verfuerth, S; Pizzey, A; Khan, N; Moss, P; Mackinnon, S; (2001) Cytomegalovirus-specific adoptive cellular therapy results in massive and persistent expansions of CMV-specific T-cells and significantly reduces the incidence of CMV reactivation following allogeneic transplantation. In: BLOOD. (pp. 779A - 779A). AMER SOC HEMATOLOGY

Peggs, KS; (2001) Exploiting graft-versus-tumour responses using donor leukocyte infusions. BEST PRACT RES CL HA , 14 (4) 723 - 739. 10.1053/beha.2001.0169.

Peggs, KS; Mackinnon, S; (2001) Cellular therapy: donor lymphocyte infusion. CURR OPIN HEMATOL , 8 (6) 349 - 354.

Peggs, KS; Mackinnon, S; (2001) Cytomegalovirus infection and disease after autologous peripheral blood stem cell transplantation. BRIT J HAEMATOL , 115 (4) 1032 - 1033.

Pickard, DCO; Bigio, IJ; Bown, SG; Lovat, LB; Ripley, PM; Novelli, M; (2001) Optical biopsy for the diagnosis of dysplasia in Barrett's oesophagus. In: (Proceedings) SPIE - The International Society for Optical Engineering. (pp. pp. 179-185).

Pickard, DCO; Bigio, IJ; Bown, SG; Lovat, LB; Ripley, PM; Novelli, M; (2001) Optical biopsy for the diagnosis of dysplasia in Barrett's oesophagus. In: Papazoglou, TG and Wagnieres, GA, (eds.) UNSPECIFIED (179 - 185). SPIE-INT SOC OPTICAL ENGINEERING

Plunkett, FJ; Soares, MVD; Annels, N; Hislop, A; Ivory, K; Lowdell, M; Salmon, M; (2001) The flow cytometric analysis of telomere length in antigen-specific CD8(+) T cells during acute Epstein-Barr virus infection. BLOOD , 97 (3) 700 - 707.

Porakishvili, N; Roschupkina, T; Kalber, T; Jewell, AP; Patterson, K; Yong, K; Lydyard, PM; (2001) Expansion of CD4<sup>+</sup> T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL). Clinical and Experimental Immunology , 126 (1) pp. 29-36. 10.1046/j.1365-2249.2001.01639.x.

Porter, JB; (2001) Deferoxamine pharmacokinetics. SEMINARS IN HEMATOLOGY , 38 (1) 63 - 68. 10.1053/shem.2001.20145.

Porter, JB; (2001) Deferoxamine pharmacokinetics. In: (pp. pp. 63-68).

Porter, JB; (2001) Practical management of iron overload. BRIT J HAEMATOL , 115 (2) 239 - 252.

Pritchard, JK; Devine, T; Lewis, I; Whelan, J; Hale, J; Campbell, B; Pagonis, C; (2001) Endogenous and induced immune responses to the 105AD7 anti-idiotypic vaccine in osteosarcoma patients following intensive chemotherapy. In:

Puar, U; Wickremasinghe, RG; Prentice, HG; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; (2001) Inhibitor of apoptosis XIAP expression in cells from B-CLL patients treated with DNA damaging agents. BLOOD , 98 (11) 181B - 182B.

Q

Quaglia, A; Bhattacharjya, S; Dhillon, AP; (2001) Limitations of the histopathogical diagnosis and prognostic assessment of hepatocellular carcinoma. HISTOPATHOLOGY , 38 (2) 167 - 174.

Quaglia, A; Dhillon, A; Colombari, R; Togni, R; Dalla Palma, P; Michelis, E; Bioulac-Sage, P; (2001) A novel scoring sytem for the histological diagnosis of hepatocellular carcinoma in cirrhotic liver. J HEPATOL , 34 105 - 105.

Quarmby, JW; Engelke, C; Chitolie, A; Morgan, RA; Belli, AM; (2001) Autologous thrombin-induced thrombosis of pseudoaneurysms. BRIT J SURG , 88 (4) 616 - 616.

Quattrocchi, E; Dallman, MJ; Dhillon, AP; Quaglia, A; Bagnato, G; Feldmann, M; (2001) Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouse liver. J IMMUNOL , 166 (10) 5970 - 5978.

R

Rai, R; Shlebak, A; Cohen, H; Backos, M; Holmes, Z; Marriott, K; Regan, L; (2001) Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. HUM REPROD , 16 (5) 961 - 965.

Reid, A; Gribble, SM; Andrews, KM; Green, AR; Nacheva, EP; (2001) Chromosome band specific FISH probes allow improved detection of terminal translocations in leukaemic metaphases. In: LEUKEMIA. (pp. 860 - 861). NATURE PUBLISHING GROUP

Reid, A; Gribble, SM; Huntly, BJP; Andrews, KM; Campbell, L; Grace, CD; Wood, ME; (2001) Variant Philadelphia translocations in chronic myeloid leukaemia can mimic typical blast crisis chromosome abnormalities or classic t(9;22): a report of two cases. In: BRIT J HAEMATOL. (pp. 439 - 442). BLACKWELL SCIENCE LTD

Reid, AG; Huntly, BJP; Campbell, L; Telford, N; Bown, N; Grace, CD; Green, AR; (2001) Extensive deletion at the t(9;22) break-point occurs in a minority of patients with Philadelphia-positive acute lymphoblastic leukaemia. BLOOD , 98 (11) 316A - 316A.

Reynard, MP; Turner, D; Lowdell, M; Navarrete, CV; (2001) Cytokine gene polymorphisms associated with outcome of bone marrow transplantation. European Journal of Immunogenetics , 28 (2) 241-.

Rezvani, A; Flanagan, AM; Sarma, U; Constantinovici, N; Bain, BJ; (2001) Investigation of ethnic neutropenia by assessment of bone marrow colony-forming cells. ACTA HAEMATOL-BASEL , 105 (1) 32 - 37.

Rhodes, DA; Stammers, M; Malcherek, G; Beck, S; Trowsdale, J; (2001) The cluster of BTN genes in the extended major histocompatibility complex. GENOMICS , 71 (3) 351 - 362. 10.1006/geno.2000.6406.

Robinson, J; Perez-Rodriguez, M; Waller, MJ; Cuillerier, B; Bahram, S; Yao, Z; Albert, ED; (2001) MICA sequences 2000. IMMUNOGENETICS , 53 (2) pp. 150-169. 10.1007/s002510100303.

Robinson, J; Waller, MJ; Parham, P; Bodmer, JG; Marsh, SGE; (2001) IMGT/HLA Database - a sequence database for the human major histocompatibility complex. NUCLEIC ACIDS RESEARCH , 29 (1) pp. 210-213. 10.1093/nar/29.1.210. Gold open access

Robinson, M; Machin, S; Mackie, I; Harrison, P; (2001) Comparison of glycocalicin, thrombopoietin and reticulated platelet measurement as markers of platelet turnover in HIV plus samples. PLATELETS , 12 (2) 108 - 113.

Rodriguez-Justo, M; Fisher, T; Wotherspoon, AC; (2001) Hodgkin's disease with an intrasinusoidal pattern of infiltration. A report of two cases. Virchows Arch , 439 (5) pp. 691-696.

Rodriguez-Viciana, P; Downward, J; (2001) Ras activation of phosphatidylinositol 3-kinase and Akt. METHOD ENZYMOL , 333 37 - 44.

Rodrguez-Justo, M; Aramburu-Gonzlez, JA; Santonja, C; (2001) Glomangiosarcoma of abdominal wall. Virchows Arch , 438 (4) pp. 418-420.

Rolfe, KJ; Crow, JC; Benjamin, E; Reid, WMN; Maclean, AB; Perrett, CW; (2001) Cyclin D1 and retinoblastoma protein in vulvar cancer and adjacent lesions. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 11 (5) 381 - 386.

Rolfe, KJ; Eva, LJ; Maclean, AB; Crow, JC; Perrett, CW; Reid, WMN; (2001) Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 11 (2) 113 - 118.

Rosette, C; Werlen, G; Daniels, MA; Holman, PO; Alam, SM; Travers, PJ; Gascoigne, NRJ; (2001) The impact of duration versus extent of TCR occupancy on T cell activation: A revision of the kinetic proofreading model. Immunity , 15 (1) pp. 59-70.

Rubin, E; Mittnacht, S; Villa-Moruzzi, E; Ludlow, JW; (2001) Site-specific and temporally-regulated retinoblastoma protein dephosphorylation by protein phosphatase type 1. Oncogene , 20 (29) pp. 3776-3785. 10.1038/sj.onc.1204518.

Rustin, GJ; Marples, M; Nelstrop, AE; Mahmoudi, M; Meyer, T; (2001) Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels. J Clin Oncol , 19 (20) pp. 4054-4057. 10.1200/JCO.2001.19.20.4054.

S

Samuels-Lev, Y; O'Connor, DJ; Bergamaschi, D; Trigiante, G; Hsieh, JK; Zhong, S; Campargue, I; (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Molecular Cell , 8 (4) pp. 781-794.

Sargent, DJ; Niedzwiecki, D; O'Connell, MJ; Schilsky, RL; (2001) Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. N Engl J Med , 345 (2) pp. 144-145. 10.1056/NEJM200107123450213.

Sarukhan, A; Soudais, C; Danos, O; Jooss, K; (2001) Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J Gene Med , 3 (3) pp. 260-270. 10.1002/jgm.175.

Saunders, MI; (2001) Programming of radiotherapy in the treatment of non-small-cell lung cancer- Away to advance care. The Lancet Oncology , 2 pp. 401-408.

Scaffidi, P; Bianchi, ME; (2001) Spatially Precise DNA Bending Is an Essential Activity of the Sox2 Transcription Factor. Journal of Biological Chemistry , 276 (50) pp. 47296-47302. 10.1074/jbc.M107619200.

Scheimberg, I; Bates, AW; Lee, A; (2001) Getting consent for necropsies - Most relatives give consent once reasons for necropsy are explained. BRIT MED J , 323 (7326) 1426 - 1426.

Schreuder, GMTH; Hurley, CK; Marsh, SGE; Lau, M; Maiers, M; Killman, C; Noreen, HJ; (2001) The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-, -B, -C, -DR and -DQ antigens. Human Immunology , 62 pp. 826-849.

Schreuder, GMTH; Hurley, CK; Marsh, SGE; Lau, M; Maiers, M; Killman, C; Noreen, HJ; (2001) The HLA dictionary 2001: a summary of HLA-A, -B, -C, DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. European Journal of Immunogenetics , 28 pp. 565-596.

Schreuder, GMTH; Hurley, CK; Marsh, SGE; Lau, M; Maiers, M; Killman, C; Noreen, HJ; (2001) The HLA dictitionary 2001: a summar of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR antigens. Tissue Antigens , 58 pp. 109-140.

Scopes, J; Massey, HM; Ebrahim, H; Horton, MA; Flanagan, AM; (2001) Interleukin-4 and interleukin-13: Bidirectional effects on human osteoclast formation. BONE , 29 (3) 203 - 208.

Scurr, JH; Machin, SJ; Bailey-King, S; Mackie, IJ; McDonald, S; Smith, PDC; (2001) Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. LANCET , 357 (9267) 1485 - 1489.

Sebire, NJ; Flanagan, AM; Goldin, RD; (2001) Osseous metaplasia in fetal mesenchyme of the human placenta. In: J PATHOL. (pp. 18A - 18A). JOHN WILEY & SONS LTD

Shah, N; Joiner, MC; Saunders, MI; (2001) An evaluation of human skin epidermal cells for hyper- radiosensitivity. British Journal of Cancer , 85 p. 16.

Shankar, A; Leonard, P; Renaut, AJ; Lederman, J; Lees, WR; Gillams, AR; Harrison, E; (2001) Neo-adjuvant therapy improves resectability rates for colorectal liver metastases. ANN ROY COLL SURG , 83 (2) 85 - 88.

Shankar, A; Leonard, P; Renaut, AJ; Lederman, J; Lees, WR; Gillams, AR; Harrison, E; (2001) Neo-adjuvant therapy improves resectability rates for colorectal liver metastases. Annals of the Royal College of Surgeons of England , 83 (2) pp. 85-88.

Sharma, SK; Bhatia, J; Pedley, RB; Spencer, DIR; Minton, N; Chester, KA; Begent, RHJ; (2001) Immunogenicity of carboxypeptidase G2 (CPG2) enzyme in ADEPT. BRIT J CANCER , 85 98 - 98.

Sharma, SK; Bhatia, J; Pedley, RB; Spencer, DIR; Minton, N; Chester, KA; Begent, RHJ; (2001) Immunogenicity of carboxypeptidase G2 (CPG2) enzyme in ADEPT. In: (pp. p. 98).

Sharma, SK; Bhatia, J; Pedley, RB; Spencer, DIR; Minton, N; Chester, KAAB; R, HJ; (2001) Immunogenicity of carboxypeptidase G2(CPG2) enzyme in ADEPT. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 98-).

Sharma, SK; Irwin, H; Pedley, RB; Bhatia, J; Dearling, J; Flynn, A; Chester, KA; (2001) Biodistribution of I-123-labelled MFE-CP fusion protein in LS174T xenografted nude mice. British Journal of Cancer , 85 p. 99.

Sharma, SK; Irwin, H; Pedley, RB; Bhatia, J; Dearling, J; Flynn, A; Chester, KA; (2001) Biodistribution of I-123-labelled MFE-CP fusion protein in LS174T xenografted nude mice. BRIT J CANCER , 85 99 - 99.

Sharma, SK; Pedley, RB; Bhatia, J; Boxer, GM; Minton, N; Chester, KA; Begent, RHJ; (2001) Optimising antibody-directed enzyme prodrug therapy (ADEPT) in human colon cancer xenografts. In: (pp. 136-).

Sharma, SK; Pedley, RB; Bhatia, J; Boxer, GM; Minton, N; Chester, KAAB; R, HJ; (2001) Optimising antibody-directed enzyme prodrug therapy (ADEPT) in human colon cancer xenografts. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 136-).

Shaw, BE; Madrigal, JA; Potter, M; (2001) Improving the outcome of unrelated donor stem cell transplantation by molecular matching. BLOOD REV , 15 pp. 167-174.

Shaw, BE; Madrigal, JA; Potter, M; (2001) Improving the outcome of unrelated donor stem cell transplantation by molecular matching. BLOOD REV , 15 (4) 167 - 174. 10.1054/blre.2001.0163.

Shaw, BE; Pay, AL; Mayor, N; Potter, MN; Prentice, GH; Goldman, JM; Robinson, J; (2001) High resolution molecular typing to ensure allele level matching for six highly polymorphic HLA antigens increases the overall survival in volunteer donor stem cell transplantation, however 'perfect' matches are found in only 10% of pairs. BLOOD , 98 (11) 668A - 668A.

Shaw, BE; Perry, D; Hoffbrand, AV; (2001) Progressive arterial thrombosis in a patient with non-Hodgkin's lymphoma, a lupus anticoagulant, factor V Leiden mutation and paraprotein, following chemotherapy. LEUKEMIA LYMPHOMA , 42 (1-2) 221 - 223.

Sheer, D; Volpi, E; Beck, S; Horton, R; Donev, R; (2001) Large-Scale chromatin structure and function in the Major Histocompatibility Complex. J MED GENET , 38 S16 - S16.

Short, S; (2001) Thalidomide as an anti-angiogenic agent in recurrent gliomas. Journal of Neuro-Oncology , 51 pp. 41-55.

Short, SC; Brada, M; (2001) The treatment of malignant celebral tumours. Hospital Medicine , 61 (11) pp. 772-777.

Short, SC; Kelly, J; mayes, CR; Woodcock, M; Joiner, MC; (2001) Low-dose hypersensitivity after fractionated low-dose irradiation. International journal of radiation biology , 77 (6) pp. 655-664.

Short, SC; Traish, D; Dowe, A; Hines, F; Gore, M; Brada, M; (2001) Thalidomide as an anti-angiogenic agent in relapsed gliomas. Journal of Neuro-Oncology , 51 (1) pp. 41-45.

Sibtain, A; Wilson, GD; Hoskin, PJ; (2001) Tumour hypoxia and vascularity in lymphoma. British Journal of Cancer , 85 p. 36.

Sierens, J; Hartley, JA; Campbell, MJ; Leathem, AJC; Woodside, JV; (2001) Effect of phytoestrogen and antioxidant supplementation on oxidative DNA damage assessed using the comet assay. MUTAT RES-DNA REPAIR , 485 (2) 169 - 176.

Sky, NRTM; (2001) Thalidomide could be used to treat lung cancer. UNSPECIFIED

Smith, PG; Thomas, HD; Barlow, HC; Griffin, RJ; Golding, BT; Calvert, AH; Newell, DR; (2001) In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activity. CLIN CANCER RES , 7 (7) 2105 - 2113.

Smyth, J; Boneterre, ME; Schellens, J; Calvert, H; Greim, G; Wanders, J; Hanauske, A; (2001) Activity of the dolastatin analogue, LU103793, in malignant melanoma. ANN ONCOL , 12 (4) 509 - 511.

Somervaille, TCP; Linch, DC; Khwaja, A; (2001) Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood , 98 (5) pp. 1374-1381. 10.1182/blood.V98.5.1374.

Somervaille, TCP; Linch, DC; Khwaja, A; (2001) Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. BLOOD , 98 (5) 1374 - 1381.

Somervaille, TCP; Linch, DC; Khwaja, A; (2001) p38 MAP kinase regulates both differentiation and apoptosis in primary human erythroid cells. BLOOD , 98 (11) 78A - 79A.

Spanswick, V; Craddock, C; Sekhar, M; Mahendra, P; Shankaranarayana, P; Hochhauser, D; Hartley, J; (2001) Repair of melphalan induced DNA interstrand crosslinks in patients who relapse after autologous stem cell transplantation for multiple myeloma. In: (pp. 3174-).

Starke, R; Drummond, O; MacGregor, I; Biggerstaff, J; Camilleri, R; Gale, R; Lee, CA; (2001) Endothelial cells express and release soluble prion protein. BLOOD , 98 (11) 247A - 248A.

Stavrou, BM; Lawrence, C; Blackburn, GM; Cohen, T; Sheridan, DJ; Flores, NA; (2001) Coronary vasomotor and cardiac electrophysiologic effects of diadenosine polyphosphates and nonhydrolyzable analogs in the guinea pig. J Cardiovasc Pharmacol , 37 (5) pp. 571-584.

Steele, JPC; O'Doherty, CA; Shamash, J; Evans, MT; Gower, NH; Tischkowitz, MD; Rudd, RM; (2001) Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma. Annals of Oncology , 12 (4) pp. 497-499.

Steele, JPC; Shamash, J; Evans, MT; Goonewardene, TI; Nystrom, ML; Gower, NH; Rudd, RM; (2001) Phase II trial of vinorelbine and oxaliplatin ('VO') in malignant pleural mesothelioma. Proceedings of ASCO , 20 1335-.

Stein, H; Marafioti, T; Foss, HD; Laumen, H; Hummel, M; Anagnostopoulos, I; Wirth, T; (2001) Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood , 97 (2) pp. 496-501.

Stein, RC; (2001) Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment. Endocr Relat Cancer , 8 (3) pp. 237-248.

Stephens, RJ; Gower, NH; Spiro, SG; Rudd, RM; on, BOTBLTSC; (2001) The Big Lung Trial (BLT): a major randomised trial to determine the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Lung Cancer , 29 (Suppl.) 20-.

Stoeber, K; Tisty, TD; Happerfield, L; Thomas, GA; Romanov, S; Bobrow, L; Williams, ED; (2001) DNA replication licensing and human cell proliferation. J CELL SCI , 114 (11) 2027 - 2041.

Stubbs, M; Khan, K; Savage, K; Smith, S; Dhillon, AP; Michaeli, D; Grimes, S; (2001) CCK-B/gastrin receptor endocytosis in liver tumour cell lines. GASTROENTEROLOGY , 120 (5) A507 - A507.

Swanton, C; Jones, N; (2001) Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY , 82 (1) pp. 3-13. 10.1046/j.1365-2613.2001.00165.x.

Sweetenham, JW; Santini, G; Qian, W; Guelfi, M; Schmitz, N; Simnett, S; Nagler, A; (2001) High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood. Journal of Clinical Oncology , 19 (11) pp. 2927-2936.

Swerdlow, AJ; Schoemaker, MJ; Allerton, R; Horwich, A; Barber, JA; Cunningham, D; Lister, TA; (2001) Lung cancer after Hodgkin's disease: A nested case-control study of the relation to treatment. J CLIN ONCOL , 19 (6) 1610 - 1618.

Szmania, S; Galloway, A; Bruorton, M; Musk, P; Aubert, G; Arthur, A; Pyle, H; (2001) Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood , 98 (3) pp. 505-512.

Szmania, S; Galloway, A; Bruorton, M; Musk, P; Aubert, G; Arthur, A; Pyle, H; (2001) Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. BLOOD , 98 (3) pp. 505-512.

T

Takimoto, K; Yaguchi, H; Miyakoshi, J; (2001) Extremely low frequency magnetic fields suppress the reduction of germination rate of Arabidopsis thaliana seeds kept in saturated humidity. Biosci Biotechnol Biochem , 65 (11) pp. 2552-2554.

Taylor, F; Cohen, H; Ebrahim, S; (2001) Long term anticoagulation or antiplatelet treatment - Reply. BRIT MED J , 323 (7306) 235 - 236.

Taylor, FC; Cohen, H; Ebrahim, S; (2001) Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BRIT MED J , 322 (7282) 321 - 326.

Taylor, I; Gillams, AR; Lees, WR; Ledermann, JA; (2001) Interstitial laser photocoagulation for recurrent colorectal liver metastases. In: Rau, BK, (ed.) PROCEEDINGS OF THE 14TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY FOR LASER SURGERY AND MEDICINE. (pp. 69 - 74). MEDIMOND S R L

Taylor, NJ; Baddeley, H; Goodchild, KA; Powell, MEB; Thoumine, M; Culver, LA; Stirling, JJ; (2001) BOLD MRI of human tumor oxygenation during carbogen breathing. Journal of Magnetic Resonance Imaging , 14 (2) pp. 156-163.

Taylor, RM; Cheeseman, P; Goldblatt, D; Davenport, M; Mieli-Vergani, G; Dhawan, A; Baker, A; (2001) Humoral immune response in children with bilary atresia splenic malformation syndrome. JOURNAL OF HEPATOLOGY , 34 p. 215.

Theil, J; Laumen, H; Marafioti, T; Hummel, M; Lenz, G; Wirth, T; Stein, H; (2001) Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. Blood , 97 (10) pp. 3191-3196.

Thiselton, DL; Alexander, C; Morris, A; Brooks, S; Rosenberg, T; Eiberg, H; Kjer, B; (2001) A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect. HUM GENET , 109 (5) 498 - 502.

Timothy, AR; Girling, DJ; Saunders, MI; Macbeth, F; Hoskin, PJ; (2001) Radiotherapy for inoperable lung cancer. Clinical Oncology , 13 (2) pp. 86-87.

Tipping, AJ; Deininger, MW; Goldman, JM; Melo, JV; (2001) Comparative microarray expression analysis of STI571-sensitive and resistant subtypes of a CML cell line. BLOOD , 98 (11) 306A - 306A.

Tipping, AJ; Mahon, FX; Lagarde, V; Goldman, JM; Melo, JV; (2001) Restoration of sensitivity to STI571 in ST1571-resistant chronic myeloid leukemia cells. BLOOD , 98 (13) 3864 - 3867.

Tipping, AJ; Pearson, T; Morgan, NV; Gibson, RA; Kuyt, LP; Havenga, C; Gluckman, E; (2001) Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa. P NATL ACAD SCI USA , 98 (10) 5734 - 5739.

Todd, R; Boddy, AV; Verrill, M; Sludden, J; Griffin, MJ; Elliott, S; Fishwick, K; (2001) Phase I and pharmacological study of CT-2103, a poly(L-glutamic acid)-paclitaxel conjugate. Clinical Cancer Research , 7 (11) 115-.

Tolner, B; Greenberg, B; Hartley, J; Hochhauser, D; (2001) Effects of the DNA minor groove binding agent ecteinascidin (ET-743) on the topoisomerase II alpha promoter. Clinical Cancer Research , 7 (11) 703-.

Tolner, B; Greenberg, B; Hartley, J; Hochhauser, D; (2001) Effects of the DNA minor groove binding agent ecteinascidin (ET-743) on the topoisomerase II alpha promoter. CLIN CANCER RES , 7 (11) 3795S - 3795S.

Tolner, B; Hartley, JA; Hochhauser, D; (2001) Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs. MOL PHARMACOL , 59 (4) 699 - 706.

Trowsdale, J; Barten, R; Haude, A; Stewart, CA; Beck, S; Wilson, MJ; (2001) The genomic context of natural killer receptor extended gene families. IMMUNOL REV , 181 20 - 38.

Truran, LN; Austin, SJ; Langabeer, SE; Kottaridis, PD; Linch, DC; Fisher, J; Burnett, AK; (2001) Quantitative bax and FLT3-ITD characterisation improve prognostic stratification in AML patients with intermediate risk cytogenetics. BLOOD , 98 (11) 578A - 578A.

Tsuzuki, S; Ivins, S; Guidez, F; Zelent, A; Enver, T; (2001) PLZF proteins can function as co-repressors of GATA-family transcription factors. BLOOD , 98 (11) 553A - 553A.

U

UCL, N; (2001) Thalidomide to be used in cancer fight. 14-.

UCL, NFP; (2001) 'Thalidomide tested against cancer'.

Ulrich, S; Helmberg, W; Wagner, T; Corell, A; Marsh, SGE; Lanzer, G; (2001) A novel HLA-DRB1 sequence, DRB1*11272. TISSUE ANTIGENS , 57 (2) pp. 175-176. 10.1034/j.1399-0039.2001.057002175.x.

V

Vacca, M; Filippini, F; Budillon, A; Rossi, V; Della Ragione, F; De Bonis, ML; Mercadante, G; (2001) MECP2 gene mutation analysis in the British and Italian Rett Syndrome patients: hot spot map of the most recurrent mutations and bioinformatic analysis of a new MECP2 conserved region. BRAIN & DEVELOPMENT S246 - S250.

Vacca, M; Filippini, F; Budillon, A; Rossi, V; Mercadante, G; Manzati, E; Gualandi, F; (2001) Mutation analysis of the MECP2 gene in British and Italian Rett syndrome females. J MOL MED-JMM , 78 (11) 648 - +.

Vanhaesebroeck, B; Leevers, SJ; Ahmadi, K; Timms, J; Katso, R; Driscoll, PC; Woscholski, R; (2001) Synthesis and function of 3-phosphorylated inositol lipids. ANNUAL REVIEW OF BIOCHEMISTRY , 70 pp. 535-602. 10.1146/annurev.biochem.70.1.535.

Varrault, A; Bilanges, B; Mackay, DJ; Basyuk, E; Ahr, B; Fernandez, C; Robinson, DO; (2001) Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus. J Biol Chem , 276 (22) pp. 18653-18656. 10.1074/jbc.C100095200.

Vassileva, VT; (2001) Somatic mutations of target genes induced by DNA damage occur in endometrial carcinomas with microsatellite instability. In: (Proceedings) American Association for Cancer Research Annual Meeting.

Venables, K; Winfield, E; Ariad, EGA; Hoskin, PJ; (2001) Dosimetric uncertainties in the delivery of breast radiotherapy. Clinical Oncology , 13 (2) S2-.

Venables, K; Winfield, E; Deighton, A; Aird, E; Hoskin, P; (2001) The START Trial - measurements in semi-anatomical breast and chest wall phantoms. Physics in Medicine and Biology , 46 (7) pp. 1937-1948.

Venables, K; Winfield, E; Deighton, A; Aird, E; Hoskin, P; (2001) A survey of radiotherapy quality control practice in the United Kingdom for the START trial. Radiotherapy And Oncology , 60 (3) pp. 311-318.

Vieira, SAD; Deininger, MWN; Sorour, A; Sinclair, P; Foroni, L; Goldman, JM; Melo, JV; (2001) Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene. GENES CHROMOSOMES & CANCER , 32 (4) pp. 353-363. 10.1002/gcc.1200.

Vig, S; Chitolie, A; Bevan, DH; Halliday, A; Dormandy, J; (2001) Thromboelastography: a reliable test? BLOOD COAGUL FIBRIN , 12 (7) 555 - 561.

Vig, S; Chitolie, A; Maurice, E; Boa, F; Bevan, DH; Halliday, A; Dormandy, J; (2001) Poor outcome following revascularization predicted by thromboelastography. BRIT J SURG , 88 (4) 621 - 622.

Virchis, A; Massey, E; Butler, T; Devaraj, P; Wright, F; Secker-Walker, L; Prentice, HG; (2001) Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RAR alpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3. British Journal of Haematology , 114 (3) pp. 551-556.

Vorechovsky, I; Kralovicova, J; Laycock, MD; Webster, ADB; Marsh, SGE; Madrigal, A; Hammarstrom, L; (2001) Short tandem repeat (STR) haplotypes in HLA: an integrated 50-kb STR/linkage disequilibrium/gene map between the RING3 and HLA-B genes and identification of STR haplotype diversification in the class III region. EUROPEAN JOURNAL OF HUMAN GENETICS , 9 (8) pp. 590-598. 10.1038/sj.ejhg.5200688.

von Messling, V; Fielding, A; Cattaneo, R; (2001) Of dogs and men: Canine distemper virus as model system for measles virus. GENE THERAPY , 8 S13-S13.

von Schlippe, M; Fowler, CJ; Harland, SJ; (2001) Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis. BRIT J CANCER , 85 (6) 823 - 826. 10.1054/bjoc.2001.2006.

W

Wald, NJ; Hackshaw, AK; (2001) Folic acid and miscarriage: An unjustified link. AM J MED GENET , 98 (2) 204 - 204.

Walker, AE; Hall-Craggs, MA; Pringle, J; Whelan, JS; Witt, JD; Cobb, JP; (2001) MR-guided percutaneous biopsy of primary bone and soft tissue tumors. In:

Wardman, P; Folkes, LK; Bentzen, SM; Stratford, MRL; Hoskin, PJ; Phillips, H; Jackson, S; (2001) Influence of plasma glutathione levels on radiation mucositis. International Journal of Radiation Oncology Biology Physics , 51 (2) pp. 460-464.

Watts, MJ; Ings, SJ; Ahmed, F; Smith, R; Mackinnon, S; Linch, DC; (2001) Clinical scale depletion of CD3+CD8+expressing T-cells from mobilised donor PBSC products using the eligix High Density Magnetic Particle (HDM) device. BONE MARROW TRANSPL , 27 S125 - S125.

Webley, SD; Francis, RJ; Pedley, RB; Sharma, SK; Begent, RHJ; Hartley, JA; Hochhauser, D; (2001) Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material. BRIT J CANCER , 84 (12) 1671 - 1676. 10.1054/bjoc.2001.1843.

Wedderburn, LR; Jeffery, R; White, H; Patel, A; Varsani, H; Linch, D; Murray, K; (2001) Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T- and B-cell repertoires, and evidence for reversion from the CD45RO(+) to RA(+) phenotype. RHEUMATOLOGY , 40 (11) 1299 - 1307.

Wendy, V; (2001) Thalidomide could treat lung cancer. Metro 9-.

Wharton, SB; Chan, KK; Anderson, JR; Stoeber, K; Williams, GH; (2001) Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis. NEUROPATH APPL NEURO , 27 (4) 305 - 313.

Whelan, JS; Cassoni, AM; Cobb, JP; (2001) Bone. In: Price, P and Sikora, K, (eds.) Treatment of Cancer. : London.

Whelan, JS; Driver, D; Brock, C; McTiernan, A; Hamilton, C; Michelagnoli, M; (2001) Hepatic veno-occlusive disease complicating high dose chemotherapy for Ewing’s sarcoma. In:

Whelan, JS; Riley, V; (2001) Navigating in difficult waters: the care of teenagers with advanced cancer. In:

Wickremasinghe, RG; Ganeshaguru, K; Jones, DT; Lindsay, C; Spanswick, VJ; Hartley, JA; Wadhwa, M; (2001) Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells. BRIT J HAEMATOL , 114 (3) 608 - 615.

Wickremasinghe, RG; Ganeshaguru, K; Jones, DT; Lindsay, C; Spanswick, VJ; Hartley, JA; Wadhwa, M;